Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1050.Time spend outdoors in summer,44959,-0.00126433146877812,0.0211973808347212,-0.0428111979048316,0.0402825349672754,0.952438427899671
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1060.Time spent outdoors in winter,41802,0.030649461910547,0.0245260770381747,-0.0174216490842754,0.0787205729053693,0.211437029945991
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X1070.Time spent watching television (TV),45980,0.00822582214550113,0.0210240466008509,-0.0329813091921667,0.0494329534831689,0.695610459640339
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X1080.Time spent using computer,41798,0.000627865326902342,0.0229244841486068,-0.044304123604367,0.0455598542581717,0.978150241524157
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X1090.Time spent driving,40857,-0.0344865533341191,0.0237048954051663,-0.080948148328245,0.0119750416600069,0.145735261511525
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1160.Sleep duration,47477,0.00337727832864767,0.01998018519932,-0.0357838846620196,0.0425384413193149,0.865773404486694
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32430,0.00625151136550132,0.0218595009743422,-0.0365931105442094,0.049096133275212,0.774895752379296
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32430,0.00718766378870912,0.0215496401430284,-0.0350496308916265,0.0494249584690447,0.738734972273554
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32430,0.00387106486935811,0.0251027498184356,-0.0453303247747756,0.0530724545134918,0.877448736734176
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32430,-0.0138300541470211,0.0260162372125392,-0.064821879083598,0.0371617707895558,0.59502157091353
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32430,0.0064140158980267,0.0265301755381702,-0.0455851281567869,0.0584131599528403,0.808969563427165
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32430,-0.0643552308092884,0.0508755678559306,-0.164071343806912,0.0353608821883355,0.205922369668693
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32430,-0.0106250785530646,0.0516599692762819,-0.111878618334577,0.0906284612284479,0.837050968143351
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32430,-0.00357324322868452,0.0372770229760953,-0.0766362082618313,0.0694897218044622,0.923636821388331
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32430,-0.00201548665258608,0.02807412136488,-0.0570407645277509,0.0530097912225787,0.94276941714376
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32430,-0.014680864041747,0.0195222886807463,-0.0529445498560098,0.0235828217725159,0.452068539604007
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32430,0.0168277740365578,0.0274891268087962,-0.0370509145086828,0.0707064625817984,0.540447418071783
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32430,-0.0116443686175969,0.0158586707166493,-0.0427273632222295,0.0194386259870356,0.462811107780137
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32430,0.00609143829997968,0.0202723078276288,-0.0336422850421727,0.045825161642132,0.763817764810139
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32430,-0.02302154007914,0.0307506412252447,-0.0832927968806197,0.0372497167223396,0.454087311115473
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32430,0.00861455074749915,0.0285535968017361,-0.0473504989839036,0.0645796004789019,0.7628899418361
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32430,0.0119214743253078,0.0350799769091873,-0.0568352804166993,0.080678229067315,0.733987606064844
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32430,-0.0719999029436443,0.0339989687306096,-0.138637881655639,-0.00536192423164947,0.0342284835778118
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32430,-0.00755995615693451,0.0225786259992962,-0.0518140631155551,0.0366941508016861,0.737763032882313
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32430,0.00166440695956357,0.0212054543742526,-0.0398982836139714,0.0432270975330986,0.937440460369184
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32430,-0.00450747146484746,0.0262935103658208,-0.0560427517818562,0.0470278088521612,0.863890462803348
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120040.Fatigue severity over the past week,32438,-0.0181407456242052,0.032782167722549,-0.0823937943604012,0.0461123031119908,0.580022884617179
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120041.Waking unrefreshed severity over the past week,32440,-0.0168766896911757,0.0330502154758821,-0.0816551120239046,0.0479017326415531,0.60961783466022
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120042.Cognitive symptoms severity over the past week,32438,-0.0390281511747637,0.0364045336948203,-0.110381037216612,0.0323247348670841,0.283719465928095
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120098.Mobility problems today,32442,-0.0372555539524948,0.0408995463254481,-0.117418664750373,0.0429075568453836,0.362371633087358
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120099.Self-care problems today,32442,-0.056772424991901,0.0636330299460562,-0.181493163686171,0.067948313702369,0.372318886832607
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120100.Problems doing usual activities,32442,-0.0392962960248979,0.0387355127228835,-0.115217900961749,0.0366253089119537,0.310383693982582
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120101.Pain or discomfort today,32442,-0.0493874475684718,0.0332612007346936,-0.114579401008471,0.0158045058715277,0.13762386011402
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120102.Anxiety or depression today,32442,-0.039438091043751,0.039725523399404,-0.117300116906583,0.0384239348190808,0.32085271277575
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120103.Scale to indicate how health is today,32413,-0.00419740393265204,0.00681518815655908,-0.0175551727195078,0.00916036485420375,0.53798373382813
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32427,-0.0648281108479769,0.0406771305572362,-0.14455528674016,0.014899065044206,0.111034811234875
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32413,-0.0859651350565267,0.0416731252444636,-0.167644460535675,-0.00428580957737808,0.0391576258602064
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32433,0.00693635406843199,0.0332302020920051,-0.058194842031898,0.072067550168762,0.834658952292646
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32434,-0.00449525089905363,0.0337134566296025,-0.0705736258930744,0.0615831240949672,0.893930003275182
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32429,-0.0525348838039389,0.0419836121667021,-0.134822763650675,0.0297529960427971,0.210852351823638
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120109.Feeling bad about self over the last two weeks,32408,-0.0836048083529958,0.0432415020049,-0.1683581522826,0.00114853557660809,0.05321512196681
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120110.Trouble concentrating over the last two weeks,32435,-0.0165357257860366,0.0420398229815616,-0.0989337788298974,0.0658623272578242,0.694081992142122
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32424,-0.109093355632893,0.0673526643104815,-0.241104577681436,0.0229178664156511,0.10532640029036
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32379,-0.0798384579230991,0.088155634946228,-0.252623502417706,0.0929465865715078,0.365144909213987
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",29988,-0.0725789433844579,0.0451226306348641,-0.161019299428792,0.0158614126598756,0.10778116501046
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44837,-0.0759561357106724,0.0493212578314931,-0.172625801060399,0.020713529639054,0.123568525452247
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43730,0.023500105539364,0.0283324712476878,-0.032031538106104,0.0790317491848321,0.406865028597356
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1289.Cooked vegetable intake,46624,-0.0225046228950479,0.0204929999704838,-0.0626709028371962,0.0176616570471004,0.272145604695809
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46177,-0.0491477316911512,0.0218996173484651,-0.0920709816941428,-0.0062244816881597,0.0248275038780717
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1309.Fresh fruit intake,46592,-0.0182437288260146,0.0217971984654519,-0.0609662378183003,0.024478780166271,0.402614939039933
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1319.Dried fruit intake,45341,-0.0288467413917049,0.0232560590910302,-0.0744286172101242,0.0167351344267143,0.214842210770348
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X134.Number of self-reported cancers,47678,0.0307919183323421,0.0447484976830006,-0.0569151371263391,0.118498973791023,0.491389799396802
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X135.Number of self-reported non-cancer illnesses,47678,0.00461069836797043,0.020064594229234,-0.0347159063213282,0.043937303057269,0.818254788829904
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X136.Number of operations, self-reported",47678,0.0388409354769132,0.0200346892003002,-0.000427055355675172,0.0781089263095016,0.0525516018398595
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X137.Number of treatments or medications taken,47678,0.0330753309798212,0.0198538108268948,-0.00583813824089268,0.0719888002005351,0.0957377800877493
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1438.Bread intake,46943,0.000868505666208794,0.00415324472874112,-0.00727185400212379,0.00900886533454138,0.834360330320631
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1458.Cereal intake,46261,0.0908360234912632,0.0208984515420321,0.0498750584688803,0.131796988513646,1.38908962304537e-05
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1488.Tea intake,46743,0.00150692455401526,0.00393446187120439,-0.00620462071354534,0.00921846982157586,0.701718486551755
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1498.Coffee intake,45728,-0.0244616264197982,0.0207858018671973,-0.0652017980795048,0.0162785452399084,0.239270967025444
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X1528.Water intake,46007,-0.0237996597207639,0.0211587107568476,-0.0652707328041852,0.0176714133626575,0.260679137216165
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1568.Average weekly red wine intake,39972,-0.0626771995646468,0.0245191868259585,-0.110734805743525,-0.0146195933857682,0.0105897618474867
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39972,0.0108085966799427,0.0249948177017192,-0.0381812460154269,0.0597984393753123,0.665432157323262
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1588.Average weekly beer plus cider intake,40010,-0.0375928754004567,0.0277031552148837,-0.0918910596216288,0.0167053088207154,0.174803689003054
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1598.Average weekly spirits intake,39947,0.023409707203196,0.027421117731109,-0.0303356835497777,0.0771550979561697,0.393277903378038
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1608.Average weekly fortified wine intake,40002,-0.00928988546448183,0.0500451962651457,-0.107378470144167,0.0887986992152037,0.852737326025839
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X1737.Childhood sunburn occasions,42158,-0.000750171006834842,0.023592301177879,-0.0469910813154777,0.045490739301808,0.974634062593809
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X1807.Father's age at death,38108,0.00843677749573027,0.00554456619199725,-0.00243057224058435,0.0193041272320449,0.128124041983914
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X1845.Mother's age,37443,0.0149580448003603,0.00831771959427767,-0.0013446856044239,0.0312607752051446,0.0721461593213846
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X1873.Number of full brothers,47255,0.00257399505056941,0.0201986079250994,-0.0370152764826255,0.0421632665837643,0.898597781465544
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X1883.Number of full sisters,47255,-0.0229525883841712,0.0200680669863149,-0.0622859996773484,0.0163808229090061,0.25274447551632
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X20015.Sitting height,47479,-0.00313898426888939,0.00525433454311059,-0.0134374799733861,0.00715951143560736,0.550240388029767
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20016.Fluid intelligence score,31451,0.0299875429877252,0.0339044939561511,-0.036465265166331,0.0964403511417815,0.376470046834161
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20018.Prospective memory result,31747,0.0374460451712208,0.0468908634104603,-0.0544600471132813,0.129352137455723,0.424558785786272
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31376,-4.47921303228345e-05,0.00723586103169221,-0.0142270797524396,0.0141374954917939,0.995061053265379
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31381,-0.00405693228354314,0.00717814004463028,-0.0181260867710185,0.0100122222039322,0.57196904054617
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20023.Mean time to correctly identify matches,47404,0.00379595680232727,0.0041795437783608,-0.0043959490032599,0.0119878626079144,0.363769835534838
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#1.Illnesses of father_Heart disease,44939,0.00571334500662934,0.00907191899934741,-0.0120676162320916,0.0234943062453503,0.528843060801161
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44572,0.00339846707725221,0.0207362864961359,-0.0372446544551741,0.0440415886096786,0.869819449365228
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44544,-0.00507166166708209,0.0275847173118164,-0.0591377075982422,0.048994384264078,0.854126920635177
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#12.Illnesses of father_Severe depression,44572,-0.00958651900135079,0.0211128600827242,-0.0509677247634901,0.0317946867607886,0.649789931310147
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44574,0.0173922538682007,0.0154387248056669,-0.0128676467509064,0.0476521544873078,0.259952458520993
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#2.Illnesses of father_Stroke,44711,0.012609337954698,0.0119131645404913,-0.010740464544665,0.035959140454061,0.289868373843856
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44655,-0.00481580829231801,0.0155394998090175,-0.0352732279179924,0.0256416113333563,0.75663436771502
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44575,-0.0257731774399391,0.0187020633515593,-0.0624292216089953,0.0108828667291171,0.168189546388714
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44688,0.00461024052604474,0.014715442285054,-0.0242320263526611,0.0334525074047506,0.754061438994238
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44804,0.0120060461522945,0.009411590122114,-0.00644067048704896,0.0304527627916379,0.202087736833871
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20107#9.Illnesses of father_Diabetes,44677,0.00555416380062892,0.0127761360796114,-0.0194870629154094,0.0305953905166672,0.663763257968737
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45818,0.00234550834430573,0.0107612508930981,-0.0187465434061666,0.023437560094778,0.827463309296756
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45714,0.00389984662642606,0.0174595558263688,-0.0303208827932567,0.0381205760461088,0.823253844593145
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45664,-0.0744909325867399,0.037346100721365,-0.147689290000615,-0.0012925751728645,0.0460977820248229
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45701,-0.00489137042262486,0.0157504067791128,-0.035762167709686,0.0259794268644363,0.756141767457412
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#2.Illnesses of mother_Stroke,45763,-0.00943953298059907,0.0128225853111878,-0.0345718001905271,0.0156927342293289,0.461638435873575
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45705,-0.0348592744717465,0.020854116734073,-0.0757333432705296,0.00601479432703661,0.0946219668763202
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45687,0.00476151987163644,0.0196059240529325,-0.0336660912721113,0.0431891310153842,0.808115141373948
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45716,-0.00035443877492948,0.0150028220706142,-0.0297599700333333,0.0290510924834744,0.981152100270358
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45722,-0.0173003519709568,0.0175386242901801,-0.0516760555797097,0.0170753516377962,0.323940706614409
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45910,-0.0086874104433334,0.00845501971197342,-0.0252592490788013,0.0078844281921345,0.30420316465943
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45768,0.00578795711547727,0.013048545361165,-0.0197871917924061,0.0313631060233607,0.65735711236882
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43399,0.0269099964316816,0.0172054193513502,-0.00681262549696483,0.060632618360328,0.117823928263533
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43308,0.0845314331360767,0.098406443870559,-0.108345196850219,0.277408063122372,0.390349433445043
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43307,-0.182083418114373,0.082282791978435,-0.343357690392106,-0.0208091458366408,0.026916253821513
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43386,-0.0138693944263535,0.0158699476400125,-0.0449744918007779,0.017235702948071,0.3821612528856
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43311,0.0546162023156641,0.0541345227215245,-0.0514874622185238,0.160719866849852,0.313036187715599
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43326,-0.0186027691283766,0.0297740588881498,-0.0769599245491502,0.0397543862923971,0.532111039836451
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43312,0.0141910070329588,0.0389097219205639,-0.0620720479313465,0.0904540619972641,0.71532720802626
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43323,0.0100661692679462,0.03528917817814,-0.0591006199612081,0.0792329584971006,0.775457145289318
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43325,0.013775434754682,0.0235849591754446,-0.0324510852291895,0.0600019547385534,0.559175203821769
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43329,0.0245503561690307,0.0312894713026804,-0.0367770075842229,0.0858777199222844,0.432685737039619
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43480,-0.00122293551396917,0.0110629427318438,-0.022906303268383,0.0204604322404446,0.911979548108559
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43388,0.0242966669842513,0.0162246221472968,-0.00750359242445048,0.056096926392953,0.13427463565943
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20127.Neuroticism score,42948,0.0138475353197179,0.0209408303347427,-0.0271964921363778,0.0548915627758137,0.508447394358179
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31451,0.0440706879547817,0.0339458545932605,-0.0224631870480088,0.110604562957572,0.194236060522911
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X20161.Pack years of smoking,30515,-0.00889321556186988,0.00826202998679506,-0.0250867943359882,0.00730036321224843,0.281789234470191
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30515,-0.00842439529173653,0.00771944698080818,-0.0235545113741206,0.00670572079064749,0.275171129192975
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20191.Fluid intelligence score,29969,0.00559425630217204,0.0360817582139582,-0.065125989797186,0.0763145024015301,0.876791845357022
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,29969,-0.00271147864468165,0.0370232934103323,-0.0752771337289329,0.0698541764395696,0.9416198464467
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X20240.Maximum digits remembered correctly,29431,0.0300520715860098,0.0384520282309037,-0.0453139037465615,0.105418046918581,0.43451403927009
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X20255.Spirometry QC measure,41534,-0.00646287469613944,0.0266024343315429,-0.0586036459859635,0.0456778965936847,0.808052387770601
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X20261.avMSE,29059,-0.00970974804583257,0.00905292750719134,-0.0274534859599276,0.00803398986826246,0.283521330903619
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X20262.Myopia diagnosis,29059,0.0437002327466777,0.0486688915222754,-0.0516907946369822,0.139091260130338,0.369275685842972
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X20280.Glucose-lactate,36961,0.00363899394800803,0.00551869391544525,-0.00717764612626466,0.0144556340222807,0.509654350209391
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X20281.Spectrometer-corrected alanine,36987,0.0008929169678299,0.00542809766991058,-0.00974615446519484,0.0115319884008546,0.86934081892351
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31245,-0.03976478077414,0.0254482607153454,-0.0896433717762169,0.010113810227937,0.118195766071778
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31243,-0.00447717437278587,0.0509647843397861,-0.104368151678767,0.0954138029331949,0.929999557365486
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31244,0.0293127287038884,0.0579379104923133,-0.0842455758610456,0.142871033268822,0.612918450964624
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31244,-0.0203037306711314,0.0246230313321265,-0.0685648720820994,0.0279574107398366,0.409635066110401
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31244,-0.0659464287019985,0.0389639910466886,-0.142315851153508,0.0104229937495111,0.0905934843752863
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31248,-0.0875802371837871,0.0506717701107516,-0.18689690660086,0.011736432233286,0.083961323651157
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31248,0.00149972991901733,0.0337888308609222,-0.0647263785683903,0.0677258384064249,0.964598418979244
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31248,0.00396962117513488,0.0367271287604925,-0.0680155511954304,0.0759547935457001,0.913931861297796
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31248,-0.0427346118710055,0.0573121643238035,-0.15506645394566,0.0695972302036493,0.455904737419864
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31248,-0.0283013376508604,0.0652104935098334,-0.156113904930134,0.099511229628413,0.664301298159349
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31248,-0.0421885153167092,0.0382109768487777,-0.117082029940314,0.0327049993068952,0.269588264690128
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31248,-0.0487219564547679,0.0644563534138583,-0.17505640914593,0.0776124962363944,0.449738845097077
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31248,0.0101662067910031,0.048364661956037,-0.0846285306428294,0.104960944224836,0.833518104582058
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31251,-0.00595976722004151,0.0663780249174522,-0.136060696058248,0.124141161618165,0.928460306556033
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31251,-0.0406580941869319,0.032836867079528,-0.105018353662807,0.023702165288943,0.215687048313828
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31251,0.00488256149608197,0.0444807701765014,-0.0822997480498608,0.0920648710420247,0.912596415741445
TFAP2A,Transcription factor AP-2-alpha,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31251,0.104377061732741,0.0747218537819167,-0.0420777716798155,0.250831895145298,0.162493214306931
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20600.Liking for adding salt to foods,33167,-0.0381941054487522,0.0290253357718635,-0.0950837635616048,0.0186955526641004,0.18824391210726
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20601.Liking for aniseed,33167,-0.0350674079453579,0.0294558174424399,-0.09280081013254,0.0226659942418243,0.233876892378415
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20602.Liking for apple juice,33167,0.0577296374834487,0.0287689947948471,0.00134240768554845,0.114116867281349,0.0448146052304061
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20603.Liking for apples,33167,-0.00743444476574349,0.0295757689582603,-0.0654029519239336,0.0505340623924466,0.801534040225284
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20604.Liking for asparagus,33167,-0.115542461817153,0.0300213842240231,-0.174384374896238,-0.0567005487380676,0.000119554853675171
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20605.Liking for aubergine,33167,-0.09388565897808,0.0290361653757251,-0.150796543114501,-0.0369747748416588,0.00122751261891295
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20606.Liking for avocados,33167,-0.0717274764633933,0.0296185000327619,-0.129779736527607,-0.0136752163991799,0.0154665915974871
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20607.Liking for bacon,33167,-0.0441468736506925,0.029502547261843,-0.101971866283905,0.0136781189825199,0.134589906368429
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20608.Liking for baked or steamed fish,33167,-0.0867201391134312,0.0294578203257316,-0.144457466951865,-0.0289828112749972,0.00324932746625041
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20609.Liking for bananas,33167,-0.00683279180476546,0.030266998223069,-0.0661561083219808,0.0524905247124499,0.821400393367318
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33167,-0.0563970923615012,0.0294379009429096,-0.114095378209604,0.00130119348660165,0.0554213573730879
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20611.Liking for beef steak,33167,-0.0544094520403234,0.0290990329749364,-0.111443556671199,0.00262465259055191,0.0615426154789696
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20612.Liking for beetroot,33167,-0.0282715148676443,0.030034971117852,-0.0871400582586342,0.0305970285233456,0.346582478547473
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20613.Liking for bell pepper,33167,-0.0528522232606552,0.0294553957019692,-0.110584798836515,0.00488035231520445,0.0727955696320784
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20614.Liking for bicycling,33167,-0.00808276841332137,0.0293384996336512,-0.0655862276952777,0.049420690868635,0.782937939845221
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20615.Liking for biscuits,33167,0.00935425579344907,0.029033801187983,-0.0475519945349977,0.0662605061218958,0.747319776218927
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20616.Liking for bitter foods,33167,-0.0308186747645657,0.0288308755944351,-0.0873271909296585,0.0256898414005272,0.285121352097041
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20617.Liking for bitter or ale,33167,-0.00670208130403128,0.0303700440183314,-0.0662273675799607,0.0528232049718982,0.825345938044072
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20618.Liking for black olives,33167,-0.061939692777851,0.030042666223561,-0.120823318576031,-0.00305606697967144,0.0392617280324056
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20619.Liking for black pepper,33167,-0.109809688740079,0.0298861331374494,-0.16838650968948,-0.0512328677906781,0.000239872065604316
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20620.Liking for blue cheese,33167,-0.101095011415681,0.029532862173916,-0.158979421276556,-0.0432106015548057,0.000621699752636424
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20621.Liking for bolognese sauce,33167,-0.0451290438838334,0.0299589612515682,-0.103848607936907,0.0135905201692402,0.132008214542194
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20622.Liking for broad beans,33167,-0.0514906208139768,0.0288918900071782,-0.108118725228046,0.00513748360009259,0.0747520985683149
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20623.Liking for broccoli,33167,-0.000732864218944595,0.0300065648246065,-0.0595457312751734,0.0580800028372842,0.9805153574282
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20624.Liking for brown rice,33167,0.0109767739947048,0.0293818668690617,-0.0466116850686561,0.0685652330580657,0.708717832927742
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20625.Liking for brussel sprouts,33167,-0.0369404259355565,0.0294329034975811,-0.0946289167908156,0.0207480649197025,0.209484008369661
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20626.Liking for burgers (meat),33167,-0.0286880761735723,0.0294251227212293,-0.0863613167071816,0.0289851643600371,0.329609536248853
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20627.Liking for burn of spicy foods,33167,-0.0456698433992087,0.0296336322562467,-0.103751762621452,0.0124120758230348,0.123314551090588
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20628.Liking for butter on bread,33167,-0.0183325331592034,0.0296219783843231,-0.0763916107924767,0.0397265444740698,0.536008726666152
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20629.Liking for butternut squash,33167,-0.0649524169418311,0.0292905220143503,-0.122361840089958,-0.00754299379370457,0.0266114329005651
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20630.Liking for cabbage,33167,-0.00724974068048152,0.0293089976523681,-0.064695376079123,0.0501958947181599,0.804638600318162
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20631.Liking for cake,33167,0.0528810811822374,0.0288685428904593,-0.00370126288306276,0.109463425247538,0.0670148257273062
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20632.Liking for cake icing,33167,0.072972426518694,0.0290520924259956,0.0160303253637426,0.129914527673645,0.0120292454928682
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20633.Liking for capers,33167,-0.0529887221580516,0.0290008158543754,-0.109830321232627,0.00385287691652408,0.0677098717735729
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20634.Liking for cauliflower,33167,-0.0260107823568272,0.0297552316137322,-0.0843310363197423,0.0323094716060879,0.382054635032791
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20635.Liking for cereal or granola bar,33167,0.0278909967664263,0.0288345725306925,-0.0286247653937311,0.0844067589265837,0.333431118838593
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20636.Liking for cheesecake,33167,0.0441465463957185,0.029007001115158,-0.0127071757899911,0.101000268581428,0.128061308020447
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20637.Liking for cherries,33167,-0.0294812090489253,0.0303468274712077,-0.0889609908924923,0.0299985727946417,0.331336660041908
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20638.Liking for chicken,33167,-0.0340670434260221,0.0304410771105208,-0.0937315545626428,0.0255974677105987,0.263120307489612
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20639.Liking for chilli pepper,33167,-0.0451557231427908,0.0297113995392907,-0.103390066239801,0.013078619954219,0.128592390080268
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20640.Liking for chips or french fries,33167,-0.0345874938177143,0.0297712818101036,-0.0929392061655174,0.0237642185300889,0.245357199344203
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20641.Liking for cigarette smoking,33167,0.046334403369199,0.0463422809327337,-0.0444964672589589,0.137165273997357,0.317418797212867
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20642.Liking for cod,33167,-0.0565670755501285,0.0296872491949661,-0.114754083972262,0.00161993287200515,0.0567545738852711
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20643.Liking for coffee with sugar,33167,-0.00218744323367913,0.0319447813959134,-0.0647992147696693,0.0604243283023111,0.945408386688854
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20644.Liking for coffee without sugar,33167,-0.0287889003542108,0.0298512997094274,-0.0872974477846885,0.0297196470762669,0.33486535100524
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20645.Liking for coriander,33167,-0.0600762248562861,0.0296606437307518,-0.11821108656856,-0.00194136314401253,0.0428494305624162
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20646.Liking for corn flakes,33167,0.0866692460033087,0.0291470024636648,0.0295411211745256,0.143797370832092,0.00295158887505277
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20647.Liking for cream,33167,0.0358754521950055,0.0289823142065153,-0.0209298836497645,0.0926807880397756,0.215806848780482
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20648.Liking for croissant,33167,-0.0317020057124292,0.029058736838573,-0.0886571299160323,0.0252531184911739,0.275317448775937
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20649.Liking for cucumber,33167,0.021998925984318,0.0293125255816667,-0.0354536241557488,0.0794514761243848,0.452975171235782
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20650.Liking for curry,33167,-0.0494987157130174,0.0296641870973821,-0.107640522423886,0.00864309099785155,0.0952233073858157
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20651.Liking for dairy products,33167,0.0202574446340575,0.0293648492072503,-0.0372976598121529,0.077812549080268,0.490303523859676
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20652.Liking for dark chocolate,33167,-0.0665201386177771,0.0296559212669528,-0.124645744301005,-0.00839453293454961,0.0249161240756549
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20653.Liking for diet fizzy drinks,33167,0.0253819826920458,0.0296447702262922,-0.032721766951487,0.0834857323355786,0.391906793774521
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20654.Liking for dried fruit,33167,-0.015064268326066,0.0291591085133297,-0.0722161210121922,0.0420875843600602,0.605431590893069
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20655.Liking for eggs,33167,0.0340478119180771,0.0307298403144877,-0.0261826750983187,0.0942782989344729,0.267902437913339
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20656.Liking for exercising alone,33167,-0.0318656788405514,0.0290670385599717,-0.0888370744180958,0.0251057167369931,0.272983661522914
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20657.Liking for exercising with others,33167,-0.0098508498767199,0.0290342950832511,-0.0667580682398921,0.0470563684864523,0.73440402527945
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20658.Liking for extra virgin olive oil,33167,-0.0496764536396966,0.0295005658123852,-0.107497562631971,0.00814465535257831,0.0922316084054784
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20659.Liking for fatty foods,33167,-0.0210168880897353,0.029428973288297,-0.0786976757347975,0.0366638995553268,0.47514843297586
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20660.Liking for fresh tomatoes,33167,-0.0299886616211944,0.0311506494383717,-0.0910439345204029,0.0310666112780141,0.335724237433235
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20661.Liking for fried chicken,33167,0.00735794588318911,0.029162471928055,-0.0498004990957987,0.0645163908621769,0.80080802763
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20662.Liking for fried or battered fish,33167,-0.0259645508250755,0.0292586031593927,-0.0833114130174852,0.0313823113673342,0.374877958265805
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20663.Liking for fruit,33167,-0.040973748188245,0.0316255260804609,-0.102959779305948,0.0210122829294584,0.195148580808794
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20664.Liking for garlic,33167,-0.0602904948839436,0.0299362435530504,-0.118965532247922,-0.00161545751996475,0.0440421388216693
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20665.Liking for gherkins,33167,-0.0452231027141683,0.0290593814187529,-0.102179490294924,0.0117332848665874,0.119687268081089
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20666.Liking for globe artichoke,33167,-0.0507689365571089,0.0291030667562383,-0.107810947399336,0.00627307428511823,0.0811131452178293
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20667.Liking for goat's cheese,33167,-0.0677535298885941,0.0290528247020789,-0.124697066304669,-0.0108099934725194,0.0197176880080134
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20668.Liking for going to a cafe,33167,0.0807375833169616,0.0292228373449746,0.0234608221208114,0.138014344513112,0.00574161330979294
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20669.Liking for going to the gym,33167,0.0242029443693172,0.0292189209926783,-0.0330661407763322,0.0814720295149666,0.407504209778458
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20670.Liking for going to the pub,33167,0.00447050374608968,0.0295113822915144,-0.0533718055452785,0.0623128130374578,0.87959717736061
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20671.Liking for grapefruit,33167,0.0369261125146531,0.0290232995602557,-0.019959554623448,0.0938117796527542,0.203301198298951
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20672.Liking for green olives,33167,-0.0739087592313087,0.0296722207445396,-0.132066311890606,-0.0157512065720111,0.0127614535812779
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20673.Liking for haddock,33167,-0.0635606774170087,0.0297292652604385,-0.121830037327468,-0.00529131750654922,0.0325440807474214
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20674.Liking for ham,33167,-0.0179896990050089,0.0295740326502658,-0.0759548029995298,0.0399754049895119,0.543007528883773
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20675.Liking for hard cheese,33167,-0.0133761281624035,0.0302979187132318,-0.0727600488403378,0.0460077925155308,0.658870953922018
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20676.Liking for herring,33167,-0.084092965978344,0.0288487885849411,-0.140636591604828,-0.0275493403518594,0.00356586978630531
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20677.Liking for honey,33167,-0.0238576574877568,0.0292600642661663,-0.0812073834494428,0.0334920684739292,0.41488380487852
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20678.Liking for horseradish or wasabi,33167,-0.0774462621488961,0.0296987093718693,-0.13565573251776,-0.0192367917800323,0.00912900594286099
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20679.Liking for ice cream,33167,0.0335481600695158,0.02943221254542,-0.0241389765195074,0.091235296658539,0.254380247360642
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20680.Liking for jam,33167,0.000172734454754328,0.0293234098929661,-0.0573011489354592,0.0576466178449679,0.995300080983222
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20681.Liking for kiwi fruit,33167,0.0367048182228094,0.0298627232187767,-0.021826119285993,0.0952357557316117,0.219058576403761
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20682.Liking for lager,33167,-0.0297554866802173,0.0291916146063201,-0.0869710513086046,0.02746007794817,0.30807938005212
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20683.Liking for lamb,33167,0.00632655944544368,0.0296676150340821,-0.0518219660213572,0.0644750849122445,0.831138209179252
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20684.Liking for lemons,33167,-0.0510136969091403,0.0294528887308695,-0.108741358821645,0.00671396500336403,0.0832989067962618
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20685.Liking for lentils or beans,33167,-0.0439664499139067,0.0294694596193609,-0.101726590767854,0.0137936909400407,0.135750720294343
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20686.Liking for liver,33167,-0.0180653466250711,0.0297901849817577,-0.0764541091893162,0.040323415939174,0.544251082518771
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20687.Liking for mackerel,33167,-0.069864996664629,0.0294321966349343,-0.1275521020691,-0.0121778912601578,0.0176281459777534
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20688.Liking for marzipan,33167,-0.000374102463200759,0.0287892766471426,-0.0568010846916002,0.0560528797651987,0.989632453888997
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20689.Liking for mayonnaise,33167,-0.0306775538599615,0.0299360390117861,-0.0893521903230622,0.0279970826031392,0.305498397710498
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20690.Liking for melon,33167,-0.0110520935896184,0.0297266700785982,-0.0693163669436709,0.0472121797644341,0.710057308135913
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20691.Liking for milk chocolate,33167,0.0108155173058081,0.0297220788836402,-0.0474397573061267,0.0690707919177428,0.715949681845076
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20692.Liking for mushrooms,33167,-0.0332318499324203,0.0308056153582026,-0.0936108560344974,0.0271471561696569,0.280722941463427
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20694.Liking for orange juice,33167,0.0509879181821986,0.0293634274813036,-0.0065643996811564,0.108540236045554,0.0825186559212019
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20695.Liking for oranges,33167,0.00266960744136315,0.0296035571053882,-0.0553533644851977,0.060692579367924,0.928147229299204
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20696.Liking for pasta,33167,-0.00553629827492504,0.0295139412767911,-0.0633836231774356,0.0523110266275856,0.851208055140479
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20697.Liking for pears,33167,-0.00101958084463951,0.0291873366225204,-0.0582267606247795,0.0561875989355005,0.972134473257546
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20698.Liking for pizza,33167,-0.0164078107207572,0.0296372146289445,-0.0744967513934885,0.0416811299519741,0.579850955339634
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20699.Liking for plain yogurt,33167,-0.0029285685275126,0.02936306390687,-0.0604801737849778,0.0546230367299526,0.920555691198981
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20700.Liking for plums,33167,-0.0188927996876825,0.02974745088963,-0.0771978034313573,0.0394122040559923,0.52537458035001
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20701.Liking for pollock,33167,-0.0351756807305112,0.0291791222229193,-0.092366760287433,0.0220153988264105,0.228037724724354
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20702.Liking for pork chop,33167,0.0126038653044586,0.0293752420744748,-0.044971609161512,0.0701793397704293,0.667886431174251
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20703.Liking for porridge,33167,0.00380928788812192,0.0296972404633797,-0.0543973034201023,0.0620158791963462,0.8979374706285
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20704.Liking for potato crisps,33167,-0.0118759625695406,0.0293181043949315,-0.0693394471836063,0.045587522044525,0.685433420432965
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20705.Liking for potatoes,33167,0.00444019506948921,0.0294113535066132,-0.0532060578034726,0.062086447942451,0.880003647343489
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20706.Liking for prawns,33167,-0.0712688595355688,0.0298472478136489,-0.129769465250321,-0.0127682538208169,0.016970025161318
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20707.Liking for raw carrots,33167,-0.0111592087710598,0.0292345898490086,-0.0684590048751166,0.046140587332997,0.702683340037301
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20708.Liking for red meat,33167,-0.0308386688896111,0.029545734644017,-0.0887483087918845,0.0270709710126623,0.296623375975768
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20709.Liking for red wine,33167,-0.0621975749100242,0.0297001353672149,-0.120409840229765,-0.00398530959028296,0.0362705181032969
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33167,0.0594978852705735,0.0298573216949745,0.000977534748423568,0.118018235792723,0.0463190845900218
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20711.Liking for roast chicken,33167,-0.0327550730721631,0.0306722262056237,-0.0928726364351856,0.0273624902908594,0.285590366093952
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20712.Liking for salad dressing,33167,-0.00735863746138597,0.0295983241547904,-0.0653713528047752,0.0506540778820033,0.803662785784424
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20713.Liking for salad leaves,33167,-0.0454010257204477,0.0298980591969026,-0.104001221746377,0.0131991703054815,0.128915466454781
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20714.Liking for salami,33167,-0.036065901860984,0.0295146162537563,-0.0939145497183464,0.0217827459963783,0.221750894959758
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20715.Liking for salmon,33167,-0.0661795776603225,0.030102403159867,-0.125180287853662,-0.00717886746698309,0.0279393577648939
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20716.Liking for salty foods,33167,-0.00260711883153409,0.0293278944646241,-0.0600897919821974,0.0548755543191292,0.929166847621787
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20717.Liking for salty pretzels,33167,-0.0104423775092149,0.0298623427561033,-0.0689725693111774,0.0480878142927476,0.726583932019534
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20718.Liking for sardines,33167,-0.0485047318878772,0.0293671178949445,-0.106064282961968,0.00905481918621402,0.0986359966804542
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20719.Liking for sausages (meat),33167,-0.0413689505896568,0.029206268481248,-0.0986132368129028,0.0158753356335892,0.156679982673675
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20720.Liking for savoury biscuits,33167,-0.0109243508581187,0.0295366527056682,-0.0688161901612283,0.046967488444991,0.711497135160118
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33167,-0.0815836816697921,0.0290032737153277,-0.138430098151834,-0.0247372651877497,0.00491979188442051
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20722.Liking for skimmed milk,33167,-0.0235602189748242,0.0287753520831133,-0.0799599090577264,0.0328394711080779,0.412942125196521
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20723.Liking for smoked fish,33167,-0.0765713111947041,0.0295969458536101,-0.13458132506778,-0.0185612973216284,0.00969278696289661
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20724.Liking for soft cheese,33167,-0.0926789235720543,0.0294585654387701,-0.150417711832044,-0.0349401353120648,0.00165998315437726
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20725.Liking for soy sauce,33167,-0.0221344656073761,0.0295325061532445,-0.0800181776677352,0.0357492464529831,0.453577874784368
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20726.Liking for soya milk,33167,0.0182456700909758,0.0293717510501655,-0.0393229619673486,0.0758143021493002,0.534484648661682
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20727.Liking for spicy foods,33167,-0.0501803793239586,0.0294536075623445,-0.107909450146154,0.00754869149823666,0.08846886184127
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20728.Liking for spinach,33167,-0.0270060813738873,0.0294962785145884,-0.0848187872624806,0.0308066245147061,0.359913127177777
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20729.Liking for spirits,33167,-0.0379858710190744,0.0290283410080241,-0.0948814193948017,0.0189096773566529,0.190709417028079
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20730.Liking for strawberries,33167,-0.00162805766023364,0.0317824192723004,-0.0639215994339424,0.0606654841134751,0.959147250178603
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33167,0.0577728991724304,0.0294469791977241,5.68199448910678e-05,0.11548897839997,0.0498004715863341
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20732.Liking for sweet foods,33167,0.0811984214679251,0.0290004123488678,0.0243576132641442,0.138039229671706,0.00512229559009067
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20733.Liking for taking the stairs,33167,0.0147428112986495,0.0302729379581377,-0.0445921470993004,0.0740777696965994,0.626272373814999
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20734.Liking for tea with sugar,33167,-0.00668314757741119,0.0353902922478222,-0.0760481203831426,0.0626818252283203,0.850221349915094
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20735.Liking for tea without sugar,33167,0.00684632035368943,0.030775890462053,-0.0534744249519345,0.0671670656593134,0.823962825140674
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20736.Liking for tomato ketchup,33167,0.0297310901884975,0.0294821393415278,-0.028053902920897,0.0875160832978919,0.313267541296649
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20737.Liking for tinned tuna,33167,0.0109268041135276,0.0289060595635048,-0.0457290726309418,0.0675826808579971,0.70543116376109
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20738.Liking for turnip (white),33167,-0.0259581715665646,0.0291891292096721,-0.0831688648175219,0.0312525216843926,0.373859743750934
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20739.Liking for vegetables,33167,-0.0426827385930483,0.0319809899795409,-0.105365478952948,0.0200000017668517,0.182030667170707
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20740.Liking for vinegar,33167,-0.0132009804092273,0.0295681786018069,-0.0711546104687689,0.0447526496503143,0.655276096353567
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20741.Liking for watching television,33167,0.0273191296539415,0.0295605009835614,-0.030619452273839,0.0852577115817219,0.355418247625662
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20742.Liking for whisky,33167,-0.0292530206796114,0.0302344795930989,-0.0885126006820852,0.0300065593228625,0.33330010885203
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20743.Liking for white bread,33167,0.0152754353353783,0.028933865291814,-0.0414349406365771,0.0719858113073337,0.597551408555608
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20744.Liking for white rice,33167,-0.012076643124677,0.029615690326967,-0.0701233961655323,0.0459701099161783,0.683445654780237
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20745.Liking for white wine,33167,-0.0333272782421646,0.0292608911230475,-0.0906786248433377,0.0240240683590084,0.25474499472167
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33167,0.0387013361217765,0.0293068546986753,-0.018740099087627,0.09614277133118,0.186682031199337
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20747.Liking for whole milk,33167,0.0739498530256841,0.0291684204058817,0.0167797490301559,0.131119957021212,0.0112522798061707
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20748.Liking for wholemeal bread,33167,0.028448289396073,0.0306554105626391,-0.0316363153066996,0.0885328940988455,0.35343050106058
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X20749.Liking for working up a sweat,33167,0.0268251053908625,0.0294972527482326,-0.0309895099956734,0.0846397207773985,0.363157160410044
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X21001.Body mass index (BMI),47562,0.00309863820056624,0.0165023304557657,-0.0292459294927346,0.0354432058938671,0.851058769818818
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X21002.Weight,47580,0.00692802592152315,0.0096799180440292,-0.0120446134447741,0.0259006652878204,0.474176728430698
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X21021.Pulse wave Arterial Stiffness index,31682,-0.00741560887094005,0.00753764959857273,-0.0221894020841426,0.0073581843422625,0.325239773656692
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32719,-0.0316651737351033,0.0316412573407327,-0.0936820381229393,0.0303516906527327,0.316972202458704
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32721,-0.0245422724352113,0.032807904847702,-0.0888457659367071,0.0397612210662847,0.454443990160817
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32721,-0.00423554576822868,0.0325133110089394,-0.06796163534575,0.0594905438092926,0.896354878327448
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21040.Satisfaction with bowel habits,32696,0.038424035265464,0.030365160205796,-0.0210916787378961,0.0979397492688241,0.205761829830645
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32693,-0.0059613506873767,0.0318312038219353,-0.0683505101783699,0.0564278088036165,0.85144533920893
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21042.Greatest number of times bowels opened per day,32685,0.0503790071477413,0.0334450330088446,-0.0151732575495941,0.115931271845077,0.132020189683972
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21043.Least number of times bowels opened per week,32635,0.0063073933672614,0.0326782685738633,-0.0577420130375106,0.0703567997720334,0.846951751463959
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21044.Average number of times bowels opened per day,32666,0.0350024842907247,0.0360432645148025,-0.0356423141582881,0.105647282739738,0.331513160575105
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32724,0.00165852317923275,0.0328976603094019,-0.0628208910271949,0.0661379373856604,0.959793118892926
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32718,-0.0219640512255889,0.032746296773886,-0.0861467929024054,0.0422186904512276,0.502407554679476
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29055,0.0260355555309927,0.0480998307476291,-0.0682401127343603,0.120311223796346,0.588336684214896
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32722,-0.00172181674496848,0.0347887696923363,-0.0699078053419476,0.0664641718520106,0.960527160727416
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32719,0.0574346704640076,0.0506327658420867,-0.0418055505864823,0.156674891514498,0.256683489956841
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32722,0.0382272315493917,0.0394736701009805,-0.0391411618485301,0.115595624947314,0.33285931640933
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32720,-0.026787795519354,0.0936164376057894,-0.210276013226701,0.156700422187993,0.774774412123445
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32723,-0.0146339290001459,0.0368960132002513,-0.0869501148726385,0.0576822568723466,0.691652609623815
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32722,-0.00640219957755008,0.0386058015617394,-0.0820695706385593,0.0692651714834591,0.8682904528138
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32503,-0.00424741537642506,0.0344863211898908,-0.071840604908611,0.0633457741557608,0.901981425862558
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32722,-0.0303143186392429,0.0338948079245472,-0.0967481421713555,0.0361195048928696,0.371151101498025
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32723,0.0157190617356376,0.0468812794908481,-0.0761682460664248,0.1076063695377,0.73741045119768
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32722,-0.014932824827732,0.0328820007487926,-0.0793815462953654,0.0495158966399015,0.649743718371721
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32721,0.000920742113821021,0.0323106039971268,-0.0624080417205475,0.0642495259481895,0.977266727574694
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X21100.Water hardness (USGS classification),47364,0.0187872826314629,0.0203589769904914,-0.0211163122699002,0.058690877532826,0.35612043632411
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2139.Age first had sexual intercourse,45037,0.00971181714467408,0.00445342028702152,0.000983113382111912,0.0184405209072363,0.0292125322547726
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2149.Lifetime number of sexual partners,43336,-0.0343157503840362,0.0227802278940453,-0.078964997056365,0.0103334962882926,0.131985074804741
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22032.IPAQ activity group,43321,-0.0232793582421259,0.0222283877324524,-0.0668469981977325,0.0202882817134808,0.294983208853765
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22033.Summed days activity,43817,-0.00486268135925554,0.00431412552717449,-0.0133183673925175,0.00359300467400646,0.259691170792233
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22034.Summed minutes activity,43321,-0.00769592665875077,0.0043910709233001,-0.016302425668419,0.000910572350917432,0.0796811267536398
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22037.MET minutes per week for walking,42661,-0.0126512350498001,0.00434207815629861,-0.0211617082361454,-0.00414076186345484,0.00357667036759337
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22038.MET minutes per week for moderate activity,43321,-0.00347775891605684,0.00450307198665754,-0.0123037800099056,0.00534826217779194,0.439941354859714
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22039.MET minutes per week for vigorous activity,43321,-0.00509255975652453,0.0221945338920326,-0.0485938461849084,0.0384087266718593,0.81852075080533
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X22040.Summed MET minutes per week for all activity,42661,-0.00587861436069309,0.00445994442592743,-0.0146201054355108,0.00286287671412467,0.187489114014368
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X2217.Age started wearing glasses or contact lenses,42845,-0.00251241206771737,0.00512143792814409,-0.0125504304068798,0.00752560627144504,0.623737899953599
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X22501.Year ended full time education,29935,0.00545041837521447,0.0231711605083779,-0.0399650562212063,0.0508658929716352,0.814042629469844
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X22506.Tobacco smoking,29895,0.040121063387033,0.0769331645754599,-0.110667939180868,0.190910065954934,0.602033864213725
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,45960,0.0171949231416798,0.0440264891975231,-0.0690969956854655,0.103486841968825,0.696127310945937
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23098.Weight,47260,0.00559478661238646,0.00975450060232949,-0.0135240345681793,0.0247136077929523,0.566271428191534
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23099.Body fat percentage,47239,0.0227956080997993,0.00943676928229981,0.00429954030649163,0.0412916758931069,0.0157162474328174
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23100.Whole body fat mass,47210,0.016587648724409,0.00897653429039073,-0.00100635848475683,0.0341816559335748,0.0646308830602138
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23101.Whole body fat-free mass,47256,-0.0104035992990514,0.00832939131069833,-0.0267292062680201,0.00592200766991734,0.211669247068216
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23102.Whole body water mass,47260,-0.0111863435348159,0.00832702389520299,-0.0275073103694138,0.00513462329978196,0.179162524429374
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23104.Body mass index (BMI),47260,0.00290108886496371,0.0166375309209293,-0.0297084717400578,0.0355106494699852,0.861576075407816
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23105.Basal metabolic rate,47258,-0.00810651758938482,0.00892560988153014,-0.0256007129571839,0.00938767777841426,0.363765424693188
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23106.Impedance of whole body,47257,0.0177420219707225,0.00683629550270341,0.00434288278542377,0.0311411611560211,0.00945760686792713
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23107.Impedance of leg (right),47257,0.00696413017767953,0.0056444599204745,-0.0040990112664505,0.0180272716218096,0.217290128270628
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23108.Impedance of leg (left),47256,0.00828855708115936,0.00558639000072071,-0.00266076732025324,0.019237881482572,0.13790056059737
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23109.Impedance of arm (right),47251,0.00933869822654566,0.00685556956951225,-0.00409821812969834,0.0227756145827897,0.173145989249436
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23110.Impedance of arm (left),47255,0.0168004392827989,0.00685197524844107,0.00337056779585444,0.0302303107697435,0.0142172025620453
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23111.Leg fat percentage (right),47256,0.00634327684079319,0.0117032331635593,-0.016595060159783,0.0292816138413694,0.587816341324794
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23112.Leg fat mass (right),47255,0.00302194419728806,0.0120901429393795,-0.0206747359638958,0.0267186243584719,0.80262738072207
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23113.Leg fat-free mass (right),47255,-0.00809940043041355,0.00896293119200688,-0.025666745566747,0.00946794470591994,0.366187503678573
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23114.Leg predicted mass (right),47254,-0.00812854487623554,0.00900212929727551,-0.0257727182988955,0.00951562854642445,0.36655747086525
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23115.Leg fat percentage (left),47253,0.00894828536609634,0.0120332404698251,-0.0146368659547608,0.0325334366869535,0.457107477440804
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23116.Leg fat mass (left),47253,0.00721092812431921,0.0125207819051962,-0.0173298044098653,0.0317516606585037,0.564676988065328
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23117.Leg fat-free mass (left),47251,-0.00828815101998742,0.00929260187600089,-0.0265016506969492,0.00992534865697431,0.37245112878397
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23118.Leg predicted mass (left),47250,-0.00897005326943882,0.00933007408991096,-0.0272569984856643,0.00931689194678666,0.33635455625072
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23119.Arm fat percentage (right),47250,0.0104174350208694,0.0104525924689152,-0.0100696462182043,0.0309045162599432,0.31895129957505
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23120.Arm fat mass (right),47249,0.0121922717703091,0.0101869993530627,-0.00777424696169382,0.0321587905023119,0.231378626283085
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23121.Arm fat-free mass (right),47248,-0.00666045422169707,0.00833596104814577,-0.0229989378760628,0.00967802943266865,0.424297041101606
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23122.Arm predicted mass (right),47247,-0.0067935484624188,0.00834162487112176,-0.0231431332098174,0.00955603628497985,0.415415263273656
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23123.Arm fat percentage (left),47244,0.0186282592006575,0.0106838739805315,-0.00231213380118436,0.0395686522024993,0.0812443482072809
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23124.Arm fat mass (left),47244,0.0158993601451751,0.0101435811698972,-0.0039820589478233,0.0357807792381735,0.117027592703833
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23125.Arm fat-free mass (left),47240,-0.0104253620827685,0.00846565863342016,-0.027018053004272,0.00616732883873498,0.218152565058618
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23126.Arm predicted mass (left),47239,-0.00854100301589582,0.00851498754223377,-0.025230378598674,0.00814837256688237,0.315844582530419
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23127.Trunk fat percentage,47237,0.016187217045488,0.00675588873011019,0.00294567513447198,0.0294287589565039,0.0165821809277547
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23128.Trunk fat mass,47233,0.0144321330030202,0.00737108104184341,-1.51858389928691e-05,0.0288794518450333,0.0502489554775535
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23129.Trunk fat-free mass,47228,-0.00940145318669617,0.00758019034151968,-0.0242586262560748,0.00545571988268241,0.214889436175193
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X23130.Trunk predicted mass,47226,-0.0107257090365669,0.00756794981098188,-0.0255588906660914,0.00410747259295755,0.156421939119503
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23400.Total Cholesterol,36991,-0.011854495652569,0.00579954397835902,-0.0232216018501527,-0.000487389454985351,0.0409695742874886
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,36991,-0.00875068783403513,0.0056191227468701,-0.0197641684179005,0.00226279274983026,0.119422193411203
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",36991,-0.00623532103985666,0.00564198360828975,-0.0172936089121046,0.00482296683239125,0.269108484918724
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23403.VLDL Cholesterol,36991,-0.00293709148350435,0.00554802250265932,-0.0138112155887166,0.00793703262170792,0.59654090161962
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23404.Clinical LDL Cholesterol,36991,-0.00976866393368954,0.00561434050701611,-0.0207727713274411,0.00123544346006203,0.0818914716958535
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23405.LDL Cholesterol,36991,-0.0104863459023721,0.00556912564486719,-0.0214018321663118,0.000429140361567638,0.0597301849813478
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23406.HDL Cholesterol,36991,-0.0137740953064216,0.00637350892977554,-0.0262661728087817,-0.00128201780406154,0.0307019368033876
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23407.Total Triglycerides,36991,0.00106552775976789,0.00569809841456945,-0.0101027451327882,0.012233800652324,0.851665812111039
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23408.Triglycerides in VLDL,36991,0.000650525075501025,0.0057900973561324,-0.0106980657425185,0.0119991158935205,0.910546569977922
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23409.Triglycerides in LDL,36991,-0.00272421184608131,0.00545111055663929,-0.0134083885370943,0.0079599648449317,0.617256995752394
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23410.Triglycerides in HDL,36991,0.00399463801050834,0.00538200029979025,-0.00655408257708055,0.0145433585980972,0.457966231644978
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,36991,-0.010777590477343,0.0057442672620879,-0.0220363543110352,0.00048117335634932,0.0606452958053167
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23412.Phospholipids in VLDL,36991,-0.00135405373235383,0.00560818485763455,-0.0123460960533175,0.0096379885886099,0.809216007412814
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23413.Phospholipids in LDL,36991,-0.00968276471968831,0.0055719685665513,-0.0206038231101289,0.00123829367075223,0.0822759032044542
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23414.Phospholipids in HDL,36991,-0.0099422031912272,0.00598002595858119,-0.0216630540700463,0.00177864768759193,0.0964226945407565
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23415.Total Esterified Cholesterol,36991,-0.0123730385741213,0.00582268502372779,-0.0237855012206278,-0.000960575927614843,0.0336076292746558
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,36991,-0.00338379588593694,0.00554909712683794,-0.0142600262545393,0.00749243448266543,0.542010051643037
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23417.Cholesteryl Esters in LDL,36991,-0.0102726297239485,0.00554693428383526,-0.0211446209202656,0.00059936147236862,0.064055827780804
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23418.Cholesteryl Esters in HDL,36991,-0.0136575264783387,0.00635901257143498,-0.0261211911183513,-0.00119386183832614,0.0317523994692664
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23419.Total Free Cholesterol,36991,-0.010361639338205,0.00573637017662717,-0.0216049248843943,0.000881646207984232,0.0708934556232462
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23420.Free Cholesterol in VLDL,36991,-0.00233823039262186,0.00557788513230878,-0.0132708852519471,0.00859442446670335,0.675079325659238
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23421.Free Cholesterol in LDL,36991,-0.0107138930644019,0.00563884811774942,-0.0217660353751908,0.000338249246386953,0.0574531043445933
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23422.Free Cholesterol in HDL,36991,-0.0136305296719579,0.00632186166055517,-0.026021378526646,-0.00123968081726972,0.0310944090449278
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,36991,-0.00911566559545994,0.00559051135121854,-0.0200730678438483,0.00184173665292839,0.103007125427786
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23424.Total Lipids in VLDL,36991,-0.000589818338778922,0.00566015611516593,-0.0116837243245041,0.0105040876469463,0.917008009359154
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23425.Total Lipids in LDL,36991,-0.0101325718401019,0.00556233044886327,-0.0210347395198739,0.000769595839670126,0.0685321437092551
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23426.Total Lipids in HDL,36991,-0.0115243628029482,0.00611479915757434,-0.0235093691517939,0.000460643545897498,0.0594968185020269
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,36991,-0.012206134964376,0.00576796410141055,-0.0235113446031407,-0.000900925325611326,0.0343470188127176
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23428.Concentration of VLDL Particles,36991,-0.00163823039031679,0.00553623996628323,-0.0124892607242319,0.00921279994359835,0.767303269534621
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23429.Concentration of LDL Particles,36991,-0.00867049563098746,0.00556681833690142,-0.0195814595713143,0.00224046830933933,0.119368416892512
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23430.Concentration of HDL Particles,36991,-0.0114710217362821,0.00576639265922914,-0.0227731513483713,-0.000168892124193012,0.0466900206002521
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23431.Average Diameter for VLDL Particles,36991,0.0018002352314852,0.00607114432524128,-0.0100992076459877,0.0136996781089581,0.766835230697019
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23432.Average Diameter for LDL Particles,36991,-0.00814651588503202,0.0055651236293167,-0.0190541581984928,0.00276112642842871,0.143258400654979
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23433.Average Diameter for HDL Particles,36991,-0.008365684665473,0.00645578358943071,-0.0210190205007572,0.00428765116981119,0.195052213594527
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23434.Phosphoglycerides,36979,-0.0102930080840797,0.00568184089349162,-0.0214294162353232,0.000843400067163925,0.07007673067593
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,36979,0.00625273764406868,0.00610825259296445,-0.00571943743814165,0.018224912726279,0.306017570243971
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23436.Total Cholines,36979,-0.0110613715950528,0.00578021919113901,-0.0223906012096852,0.000267858019579703,0.0556854101365695
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23437.Phosphatidylcholines,36979,-0.0110236640322706,0.00576252053360751,-0.0223182042781414,0.000270876213600084,0.0557706373939702
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23438.Sphingomyelins,36978,-0.00942364190413583,0.00597283050418315,-0.0211303896923348,0.00228310588406315,0.114646836990092
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23439.Apolipoprotein B,36991,-0.00767414252864818,0.00558815509232044,-0.0186269265095962,0.0032786414522999,0.169686490606846
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23440.Apolipoprotein A1,36991,-0.0107523707551914,0.00594247948861222,-0.0223996305528714,0.000894889042488517,0.0704104767085877
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,36991,-0.000783075984208192,0.00558058574383022,-0.0117210240421154,0.010154872073699,0.888408155334766
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23442.Total Fatty Acids,36979,-0.00676318567787886,0.00544640322956414,-0.0174381360078246,0.00391176465206685,0.21434325874201
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23443.Degree of Unsaturation,36979,-0.0106754200570622,0.00604255737957743,-0.022518832521034,0.00116799240690955,0.0773007913222635
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23444.Omega-3 Fatty Acids,36979,-0.00940838577184397,0.00555214192436325,-0.0202905839435959,0.001473812399908,0.0901844274891492
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23445.Omega-6 Fatty Acids,36979,-0.0105761561423724,0.00553222739791086,-0.0214193218422777,0.000267009557532867,0.0559318757167281
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,36979,-0.0111372487848868,0.00553865985956787,-0.0219930221096399,-0.000281475460133815,0.0443648793303099
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23447.Monounsaturated Fatty Acids,36979,-0.00289381144209526,0.00553849975363168,-0.0137492709592133,0.00796164807502283,0.601337941184392
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23448.Saturated Fatty Acids,36979,-0.00554021940696811,0.00547164898782419,-0.0162646514231035,0.00518421260916729,0.311302452965396
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23449.Linoleic Acid,36979,-0.00889214787738242,0.00557266770363652,-0.01981457657651,0.00203028082174516,0.110586208132921
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23450.Docosahexaenoic Acid,36979,-0.00772625020131715,0.00580086584068006,-0.0190959472490501,0.00364344684641576,0.182911827803103
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,36979,-0.00813706824653098,0.00561839398218175,-0.0191491204516072,0.00287498395854526,0.147559641380551
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,36979,-0.00209893925129304,0.00569578794641059,-0.0132626836262578,0.00906480512367171,0.712500973422399
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,36979,-0.00596880338522608,0.00592619784541046,-0.0175841511622306,0.00564654439177843,0.313862363663577
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,36979,0.00629833536347398,0.00607174646918826,-0.005602287716135,0.018198958443083,0.299606532999356
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,36979,0.00146176481969636,0.00544909428636176,-0.0092184599815727,0.0121419896209654,0.788504712654416
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,36979,-0.00329242396659419,0.0058322521831994,-0.014723638245665,0.00813879031247664,0.572409831850295
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,36979,-0.00407670635079078,0.00585926960204385,-0.0155608747707967,0.00740746206921516,0.486584954389138
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,36979,-0.00650662717562619,0.00606247540190412,-0.0183890789633583,0.0053758246121059,0.283173120801334
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,36977,0.00693600556490816,0.00557005589543262,-0.00398130399013977,0.0178533151199561,0.213069141660794
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23460.Alanine,36987,0.000398314188628694,0.00540370510403072,-0.0101929478152715,0.0109895761925289,0.94124122132811
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23461.Glutamine,36955,-0.0107916428235444,0.00536742181815791,-0.0213117895871339,-0.000271496059954883,0.0443900666897105
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23462.Glycine,36975,0.00909335041718521,0.0056053428538855,-0.00189312157643037,0.0200798224108008,0.104770698036306
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23463.Histidine,36976,0.00517782965275275,0.00534305620769918,-0.00529456051433765,0.0156502198198432,0.332524942950984
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),36979,-0.00165014172015485,0.0057146790812683,-0.0128509127194407,0.00955062927913102,0.772773491503871
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23465.Isoleucine,36989,-0.00155610553228259,0.00556626642710864,-0.0124659877294155,0.00935377666485034,0.779819490628139
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23466.Leucine,36990,-0.0025431795893293,0.00573469389618844,-0.0137831796258586,0.00869682044720005,0.657431243674021
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23467.Valine,36979,-0.000843528469436156,0.00569558692031131,-0.0120068788332463,0.010319821894374,0.882264456400737
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23468.Phenylalanine,36988,0.00597441637476323,0.00537308440965146,-0.00455682906815364,0.0165056618176801,0.266194802399923
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23469.Tyrosine,36976,0.00160322936118351,0.00552625589939707,-0.00922823220163474,0.0124346909240018,0.771735666678032
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23470.Glucose,36970,0.00288532454437537,0.00552827767573633,-0.00795009970006783,0.0137207487888186,0.601734112019398
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23471.Lactate,36969,0.00212320100531115,0.00542848798948966,-0.00851663545408858,0.0127630374647109,0.695713426296328
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23472.Pyruvate,36952,-0.00560369647960712,0.00535793581475776,-0.0161052506765323,0.00489785771731807,0.295641042610003
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23473.Citrate,36990,0.00363407023519198,0.00548760794752981,-0.00712164134196644,0.0143897818123504,0.507834096130611
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23474.3-Hydroxybutyrate,36782,0.00140565053867062,0.00536843260825265,-0.00911647737350457,0.0119277784508458,0.793451823991705
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23475.Acetate,36982,-0.000360229422283358,0.00534635924402454,-0.0108390935405715,0.0101186346960047,0.946281447684143
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23476.Acetoacetate,36991,-0.00491575842565316,0.00532921241117995,-0.0153610147515659,0.00552949790025954,0.356327828410049
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23477.Acetone,36991,-0.00326149371747461,0.0053477858137466,-0.013743153912418,0.00722016647746873,0.541953576579447
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23478.Creatinine,36657,-0.00182101766922696,0.00678362298402594,-0.0151169187179178,0.0114748833794639,0.788362494003783
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23479.Albumin,36990,-0.00332422303369072,0.00548708416717924,-0.014078908001362,0.00743046193398058,0.544640196179377
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23480.Glycoprotein Acetyls,36991,0.0108502450775096,0.00573369289046146,-0.000387792987794905,0.022088283142814,0.0584642180258329
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,36991,0.00149068520135719,0.00576576786698516,-0.00981021981793372,0.0127915902206481,0.795993755898761
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,36991,0.00146475351377523,0.00579254613543436,-0.00988863691167612,0.0128181439392266,0.800373648589562
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,36991,0.00142788437088444,0.00580889983840984,-0.00995755931239885,0.0128133280541677,0.805833330493676
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,36991,0.00233340153756546,0.00575212898835695,-0.00894077127961416,0.0136075743547451,0.684999954083565
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,36991,0.00296878604184771,0.00576658015972173,-0.00833371107120689,0.0142712831549023,0.606683202367286
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,36991,0.00241529696162992,0.00571060208661294,-0.00877748312813144,0.0136080770513913,0.672338947648334
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,36991,0.00201667570692214,0.00578764517911687,-0.00932710884414693,0.0133604602579912,0.727511639635178
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,36991,0.00111468210110503,0.00585245616666752,-0.0103561319855633,0.0125854961877734,0.848948509734402
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,36991,0.00102174062343211,0.00586000427300694,-0.0104638677516615,0.0125073489985257,0.861586539805238
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,36991,0.000395292839703908,0.00582826381401654,-0.0110281042357685,0.0118186899151763,0.945927225334015
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,36991,0.000147765856674082,0.00573713946761752,-0.0110970274998563,0.0113925592132044,0.979452335623685
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,36991,-0.000151674252894622,0.00568301261806086,-0.0112903789842939,0.0109870304785047,0.978708146114124
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,36991,0.000534738290453404,0.00577860220967764,-0.0107913220405148,0.0118607986214216,0.92627228787391
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,36991,0.000856538442107306,0.00591868246336961,-0.0107440791860971,0.0124571560703117,0.884935940837649
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23495.Concentration of Large VLDL Particles,36991,0.00130444951702477,0.00578965836151788,-0.0100432808715503,0.0126521799055998,0.821744100286099
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23496.Total Lipids in Large VLDL,36991,0.00104357494990294,0.00579350279570004,-0.0103116905296691,0.012398840429475,0.857054470871663
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23497.Phospholipids in Large VLDL,36991,0.00136618043968015,0.00582954115243519,-0.0100597202190928,0.0127920810984531,0.814713267829688
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23498.Cholesterol in Large VLDL,36991,0.000709380340505586,0.00569271709094065,-0.0104483451577381,0.0118671058387493,0.900832707841782
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,36991,0.000239069971345024,0.00559884476956212,-0.0107346657769967,0.0112128057196868,0.9659414285133
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,36991,0.00105836623597636,0.00579791837202747,-0.0103055537731975,0.0124222862451502,0.855159860117351
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23501.Triglycerides in Large VLDL,36991,0.000649373170780176,0.00582607827640284,-0.0107697402509694,0.0120684865925297,0.911253492897896
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,36991,-0.00375290894191547,0.005539371861564,-0.0146100777905809,0.00710425990674998,0.498102480452305
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23503.Total Lipids in Medium VLDL,36991,-0.00267828941555729,0.00555901944937747,-0.0135739675363371,0.00821738870522256,0.629961957534562
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23504.Phospholipids in Medium VLDL,36991,-0.00428938101978926,0.00554143516542463,-0.0151505939440215,0.00657183190444301,0.438911624307544
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23505.Cholesterol in Medium VLDL,36991,-0.00687277123103153,0.00559719174402537,-0.0178432670493213,0.00409772458725819,0.219507895178342
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,36991,-0.00798134437049356,0.00566162051348647,-0.019078120576927,0.00311543183593992,0.158643728277231
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,36991,-0.00528046597885832,0.0055377853059717,-0.0161345251785628,0.0055735932208462,0.340337184527663
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23508.Triglycerides in Medium VLDL,36991,0.000277526063390529,0.0056999413070581,-0.0108943588984433,0.0114494110252244,0.961167656054752
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23509.Concentration of Small VLDL Particles,36991,-0.000849818055828331,0.00555882543695145,-0.0117451159122532,0.0100454798005965,0.878497410271937
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23510.Total Lipids in Small VLDL,36991,-0.00158976892079642,0.00554619311956822,-0.0124603074351501,0.00928076959355728,0.774391383991527
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23511.Phospholipids in Small VLDL,36991,-0.00406789387362023,0.00551036107849678,-0.0148682015874739,0.00673241384023346,0.460390092200231
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23512.Cholesterol in Small VLDL,36991,-0.00385681500948703,0.00552171385878768,-0.0146793741727109,0.00696574415373682,0.48488848960242
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,36991,-0.00274384521944728,0.00553091048287828,-0.0135844297658887,0.00809673932699414,0.619837197370662
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,36991,-0.00582062420779992,0.0055255006600784,-0.0166506055015536,0.00500935708595374,0.29217196245433
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23515.Triglycerides in Small VLDL,36991,0.00181737678619816,0.00562124730739505,-0.00920026793629613,0.0128350215086925,0.74646949346746
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,36991,-0.00262948084063957,0.00556372849522349,-0.0135343886912776,0.00827542700999847,0.636498388791766
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,36991,-0.00273004747316782,0.00554470609835376,-0.0135976714259412,0.00813757647960554,0.622465967278772
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,36991,-0.0022279345251286,0.00550826893310752,-0.0130241416340193,0.00856827258376213,0.6858730560955
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,36991,-0.00490975797126385,0.00575184797171437,-0.016183379995824,0.00636386405329632,0.393344104273224
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,36991,-0.00560904085421149,0.00582950698650787,-0.0170348745477669,0.00581679283934393,0.335976409863131
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,36991,-0.00329552357455014,0.00558281272770941,-0.0142378365208606,0.0076467893717603,0.555000991770483
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,36991,0.00113547447024227,0.00546819850522133,-0.00958219459999154,0.0118531435404761,0.835505045375524
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23523.Concentration of IDL Particles,36991,-0.0060249284985949,0.00572666970289299,-0.0172492011162651,0.00519934411907536,0.292781098837314
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23524.Total Lipids in IDL,36991,-0.0089982652442418,0.0058611780532529,-0.0204861742286175,0.00248964374013389,0.124751063462
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23525.Phospholipids in IDL,36991,-0.010078919934019,0.00585224015047114,-0.0215493106289425,0.0013914707609044,0.0850509038197056
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23526.Cholesterol in IDL,36991,-0.00903115321121013,0.00589976035429352,-0.0205946835056254,0.00253237708320517,0.125851297360988
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23527.Cholesteryl Esters in IDL,36991,-0.00875817000243724,0.00589527163032409,-0.0203129023978725,0.00279656239299798,0.137402027179669
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23528.Free Cholesterol in IDL,36991,-0.00955239805397836,0.00588631865713142,-0.0210895826219559,0.00198478651399923,0.104653260157406
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23529.Triglycerides in IDL,36991,-0.000514702269774613,0.0053992382380963,-0.0110972092164434,0.0100678046768941,0.924055215396849
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23530.Concentration of Large LDL Particles,36991,-0.00955904687628505,0.00557824095492727,-0.0204923991479425,0.00137430539537239,0.0866201104368578
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23531.Total Lipids in Large LDL,36991,-0.0108894837996707,0.0056098764063582,-0.0218848415561328,0.000105873956791347,0.0522642166281637
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23532.Phospholipids in Large LDL,36991,-0.00971019297657015,0.00562407591620751,-0.0207333817723369,0.00131299581919658,0.0842737996399813
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23533.Cholesterol in Large LDL,36991,-0.0114274156370082,0.00562003959836165,-0.022442693249797,-0.000412138024219317,0.0420388942856821
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,36991,-0.0115735587504231,0.00558733209858183,-0.0225247296636435,-0.000622387837202721,0.0383415990504235
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23535.Free Cholesterol in Large LDL,36991,-0.0107471843235662,0.005716031281243,-0.0219506056348025,0.00045623698767005,0.0601052717833567
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23536.Triglycerides in Large LDL,36991,-0.00262841792953862,0.00542078631153355,-0.0132531591001444,0.00799632324106714,0.627771251593862
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23537.Concentration of Medium LDL Particles,36991,-0.00618715126824876,0.00553540635899136,-0.0170365477318718,0.00466224519537429,0.263698027252088
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23538.Total Lipids in Medium LDL,36991,-0.0083066940191352,0.00551402967739574,-0.0191141921868309,0.00250080414856046,0.131971839935461
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23539.Phospholipids in Medium LDL,36991,-0.00849782929172122,0.0055061493588364,-0.0192898820350406,0.00229422345159812,0.122773777686583
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23540.Cholesterol in Medium LDL,36991,-0.00840729413154512,0.00551533615552514,-0.0192173529963744,0.00240276473328415,0.127445772182414
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,36991,-0.00743777351112544,0.00552185553248291,-0.0182606103547919,0.00338506333254106,0.178013153651324
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,36991,-0.010426197874849,0.00552070423766174,-0.021246778180666,0.000394382430968045,0.058972426469059
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23543.Triglycerides in Medium LDL,36991,-0.0032228685954018,0.00549434163131439,-0.013991778192778,0.0075460410019744,0.557496185158751
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23544.Concentration of Small LDL Particles,36991,-0.00751316832235097,0.00556536005447072,-0.0184212740291136,0.00339493738441164,0.17704315743251
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23545.Total Lipids in Small LDL,36991,-0.00956430317157472,0.005556445071338,-0.0204549355113972,0.00132632916824775,0.0852201407509465
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23546.Phospholipids in Small LDL,36991,-0.0111894690831989,0.00557217959597504,-0.02211094109131,-0.000267997075087812,0.0446535806272895
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23547.Cholesterol in Small LDL,36991,-0.00902762341204372,0.00554644608077914,-0.0198986577303708,0.0018434109062834,0.103625008150746
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,36991,-0.00806374529137638,0.00554946518022889,-0.018940697044625,0.00281320646187225,0.146229020208041
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23549.Free Cholesterol in Small LDL,36991,-0.0102353310548752,0.00553369526006536,-0.0210813737646033,0.000610711654852873,0.0643882487230731
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23550.Triglycerides in Small LDL,36991,-0.0020217521941801,0.00556177803538563,-0.0129228371435359,0.00887933275517573,0.716231103976377
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,36991,-0.011861989048232,0.00651235009155406,-0.024626195227678,0.000902217131213929,0.0685596138634522
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23552.Total Lipids in Very Large HDL,36991,-0.00987946143554025,0.0065236929439829,-0.0226658996057467,0.00290697673466623,0.129949232507421
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23553.Phospholipids in Very Large HDL,36991,-0.00804015252835553,0.00644349737116718,-0.0206694073758432,0.00458910231913214,0.212129032108552
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23554.Cholesterol in Very Large HDL,36991,-0.011850590853753,0.00663119266627175,-0.0248477284796456,0.00114654677213962,0.0739447161370599
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,36991,-0.0126150785295229,0.00671314191196527,-0.0257728366769748,0.000542679617929056,0.0602445599208986
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,36991,-0.00848556378804826,0.00623132868668787,-0.0206989680139565,0.00372784043785997,0.173297526129006
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23557.Triglycerides in Very Large HDL,36991,-0.00187787094234208,0.00528906566565691,-0.0122444396470296,0.00848869776234546,0.722559510446776
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23558.Concentration of Large HDL Particles,36991,-0.011737182374301,0.00667448795941654,-0.0248191787747574,0.0013448140261554,0.0786833362165465
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23559.Total Lipids in Large HDL,36991,-0.0108653137493805,0.00657348719317144,-0.0237493486479965,0.0020187211492355,0.0983752236018579
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23560.Phospholipids in Large HDL,36991,-0.0101121235247932,0.00643024927406971,-0.0227154121019698,0.00249116505238341,0.115838676805813
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23561.Cholesterol in Large HDL,36991,-0.0118988194852439,0.00673245067428693,-0.0250944228068463,0.0012967838363585,0.0771873150172394
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,36991,-0.011887741181529,0.00674507051073952,-0.0251080793825784,0.00133259701952052,0.0780192702784443
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23563.Free Cholesterol in Large HDL,36991,-0.011775639659831,0.00663947298537062,-0.0247890067111575,0.00123772739149538,0.0761557415590543
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23564.Triglycerides in Large HDL,36991,0.00159766115318536,0.00532971808825688,-0.00884858629979812,0.0120439086061688,0.764361415123455
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23565.Concentration of Medium HDL Particles,36991,-0.00949906333046033,0.00587173289042723,-0.0210076597956977,0.00200953313477704,0.105738028156475
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23566.Total Lipids in Medium HDL,36991,-0.00843146664767128,0.00577663361128616,-0.0197536685257921,0.00289073523044959,0.144429091568515
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23567.Phospholipids in Medium HDL,36991,-0.00723957466960508,0.00567893056400122,-0.0183702785750475,0.0038911292358373,0.202397985037512
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23568.Cholesterol in Medium HDL,36991,-0.0104208021466989,0.00596214135190904,-0.0221065991964406,0.00126499490304282,0.0805170551817748
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,36991,-0.0102834013855465,0.00594905701729211,-0.0219435531394391,0.00137675036834599,0.0839083883020894
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,36991,-0.0106167506729633,0.00598104151393549,-0.0223395920402769,0.00110609069435024,0.0759099502362453
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23571.Triglycerides in Medium HDL,36991,0.00482352125938421,0.00540062827619006,-0.00576171016194831,0.0154087526807167,0.371798163820383
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23572.Concentration of Small HDL Particles,36991,-0.00751754484587248,0.00535298203137603,-0.0180093896273695,0.00297429993562454,0.160233604332159
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23573.Total Lipids in Small HDL,36991,-0.00533700425815648,0.00538359130414944,-0.0158888432142894,0.00521483469797641,0.321534693995821
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23574.Phospholipids in Small HDL,36991,-0.0043649971518515,0.00539312777024525,-0.0149355275815322,0.0062055332778292,0.418321141422059
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23575.Cholesterol in Small HDL,36991,-0.00787079243040942,0.00534657215001317,-0.0183500738444352,0.00260848898361638,0.141012611510148
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,36991,-0.00764386184419908,0.00532327493528737,-0.0180774807173623,0.00278975702896417,0.151045458425347
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23577.Free Cholesterol in Small HDL,36991,-0.00810331751856198,0.00544089371386257,-0.0187674691977326,0.00256083416060865,0.136422994865493
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23578.Triglycerides in Small HDL,36991,0.00452705771624627,0.00581189644231112,-0.00686425931068353,0.0159183747431761,0.436035269208037
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36363,0.00508380735311523,0.00541158216576953,-0.00552289369179306,0.0156905083980235,0.347527716587742
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36363,0.0059927313567665,0.00540519171905274,-0.00460144441257688,0.0165869071261099,0.267581322951012
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36363,0.00924204627468322,0.00535482011374884,-0.0012534011482645,0.0197374936976309,0.0843846589939239
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36363,0.00122343886150243,0.00547580711741052,-0.00950914308862219,0.011956020811627,0.823207453035174
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36363,-0.00708386384469904,0.00529735246476745,-0.0174666746756432,0.00329894698624516,0.181166650362908
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,36827,0.000974344314936567,0.00528632999904356,-0.00938686248318881,0.0113355511130619,0.853770060251863
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,36827,-0.00338971924422258,0.00592932497803237,-0.015011196201166,0.00823175771272087,0.56754381115134
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,36827,-0.00327957584367674,0.00590537744791962,-0.0148541156415992,0.00829496395424571,0.578662030934222
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,36827,-0.000599378129456397,0.00565679255490717,-0.0116866915370744,0.0104879352781617,0.915617917235419
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,36827,-0.000548211519230797,0.00575613979525955,-0.0118302455179395,0.0107338224794779,0.924126116986997
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,36987,0.00170582518265763,0.00575714451431155,-0.00957817806539301,0.0129898284307083,0.767007893175697
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,36987,-0.000547203201345557,0.00551306507108783,-0.0113528107406777,0.0102584043379866,0.920936756668422
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,36987,-0.0024628286189958,0.00575902845141727,-0.0137505243837737,0.00882486714578205,0.668915488366842
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,36987,0.00418571710990386,0.00537690991754892,-0.00635302632849202,0.0147244605482997,0.436311053699793
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,36987,-0.00383178922447351,0.00529281852851335,-0.0142057135403597,0.00654213509141266,0.469103156302846
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,36991,-0.0068409616348146,0.00581390375742872,-0.0182362129993749,0.00455428972974569,0.239354379106573
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,36991,-0.00728971212725352,0.00606664047264435,-0.0191803274536364,0.0046009031991294,0.229537852661932
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,36991,-0.00688907969048369,0.00608711084308734,-0.0188198169429349,0.00504165756196749,0.257760774623601
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,36991,-0.00810464557428391,0.00594577839182732,-0.0197583712222654,0.00354908007369763,0.172876751419614
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,36991,0.00736739325888058,0.00602884351731966,-0.00444914003506596,0.0191839265528271,0.221720375184386
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,36991,-0.00942559219976151,0.00579198685087368,-0.0207778864274739,0.00192670202795091,0.103686689285115
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,36991,-0.00506499115290305,0.00558424369312849,-0.0160101087914349,0.00588012648562879,0.364415664350164
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,36991,-0.00122726658495273,0.00541970686554217,-0.0118498920414154,0.00939535887150992,0.820858703864108
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,36991,-0.00947591193464677,0.0058374756036807,-0.0209173641178609,0.00196554024856739,0.104551571026616
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,36991,0.00649603606459079,0.00564793362652421,-0.00457391384339666,0.0175659859725782,0.25009828752913
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,36991,0.00521280442323653,0.00564105795212691,-0.0058436691629322,0.0162692780094053,0.355460207042196
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,36991,-0.00621931763302443,0.00595150697200644,-0.017884271298157,0.00544563603210819,0.296042761493063
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,36991,-0.0066270080544985,0.00602007493255983,-0.0184263549223158,0.00517233881331877,0.270995967592547
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,36991,-0.00145496933847789,0.00540674381716764,-0.0120521872201265,0.00914224854317068,0.787854883724484
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,36991,0.00557175312424285,0.00588791044493615,-0.00596855134783201,0.0171120575963177,0.344010973804036
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,36991,-0.00366497619543737,0.00545768040635015,-0.0143620297918837,0.00703207740100892,0.501897093152208
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,36991,-0.00434710629355707,0.00571527084161551,-0.0155490371431235,0.00685482455600933,0.446902224354817
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,36991,-0.00291141675867373,0.00565949419452276,-0.0140040253799383,0.00818119186259087,0.606959656646466
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,36991,-0.00409117449635269,0.00556625012273282,-0.015001024736909,0.00681867574420363,0.462354736718034
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,36991,0.00740534401967102,0.00576809757787879,-0.00390012723297141,0.0187108152723134,0.1992188003937
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,36991,0.0105887162479767,0.00543839491823235,-7.05377917586958e-05,0.0212479702877121,0.0515524690738839
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,36991,-0.0154464054688052,0.0057217601512326,-0.026661055365221,-0.00423175557238926,0.00695139160454028
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,36991,-0.0141986439885452,0.00536611417161292,-0.0247162277649065,-0.00368106021218387,0.00815511218375545
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,36991,-0.00283541859579019,0.00604310086840179,-0.0146798962978577,0.00900905910627732,0.638934987890801
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,36991,0.00787708701035665,0.0055884383871392,-0.00307625222843618,0.0188304262491495,0.158701374759552
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,36991,0.00124239488218821,0.00538898526787684,-0.00932001624285039,0.0118048060072268,0.817673149783287
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,36991,-0.00458479059046655,0.00560268475873215,-0.0155660527175816,0.00639647153664846,0.413189175454273
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,36991,0.00231116707518322,0.00557362564260978,-0.00861313918433195,0.0132354733346984,0.678396611492254
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,36991,-0.00818291307176101,0.00585722990027073,-0.0196630836762917,0.00329725753276962,0.16241854785958
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,36991,0.00437713575455144,0.00545655737485337,-0.00631771670016118,0.0150719882092641,0.422463937559456
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,36991,-0.00415460693536745,0.00551452558281442,-0.0149630770776837,0.00665386320694881,0.451227081786565
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,36991,0.000465618561962698,0.00541695545863603,-0.0101516141369639,0.0110828512608893,0.931502890271949
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,36991,0.0037731058466774,0.00552098140421777,-0.00704801770558943,0.0145942293989442,0.494358494350227
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,36991,-0.00542689403039623,0.00557530007671015,-0.0163544821807481,0.00550069411995567,0.330381653286915
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,36991,0.00546070591121204,0.00560603607554044,-0.00552712479684721,0.0164485366192713,0.330036685123542
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,36987,-0.00139189974969426,0.00609526732228273,-0.0133386237013684,0.0105548242019799,0.81937191649514
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,36987,-0.00214787700211625,0.00559603492614422,-0.0131161054573589,0.00882035145312643,0.701117168948543
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,36987,-0.00790841787678119,0.00534661395032455,-0.0183877812194173,0.00257094546585493,0.139125531647596
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,36987,0.00950108161009621,0.00645100430790396,-0.00314288683339555,0.022145050053588,0.140827172492775
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,36987,0.0063576084491917,0.00599614735066679,-0.0053948403581152,0.0181100572564986,0.289035731389917
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,36991,0.00709061763971251,0.00603777211631483,-0.00474341570826457,0.0189246509876896,0.240265554096086
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,36991,-0.0113019149143888,0.00615408557101503,-0.0233639226335783,0.000760092804800648,0.0663078523853303
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,36991,-0.00935959665121313,0.00594032366680451,-0.02100263103815,0.00228343773572371,0.115141226080442
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,36991,-0.00975547244063449,0.00604257010679912,-0.0215989098499608,0.00208796496869177,0.106452261946629
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,36991,0.0107775475294363,0.00582260689648688,-0.000634761987677967,0.0221898570465506,0.0641944112736438
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,36991,0.0128351156339366,0.0060836851531625,0.000911092733738097,0.0247591385341351,0.0348979032940125
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,36991,-0.0123130136838482,0.00595306464464535,-0.0239810203873531,-0.000645006980343348,0.0386267741450098
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,36991,-0.00945409521824346,0.00568387263106641,-0.0205944855751336,0.00168629513864671,0.0962723952634051
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,36991,-0.0160399717920232,0.0064441614459703,-0.0286705282261249,-0.00340941535792139,0.0128200450556624
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,36991,0.0107874309967899,0.00578092149787046,-0.000543175139036164,0.0221180371326161,0.0620580407390662
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,36991,0.00432853328093407,0.00536894959556959,-0.00619460792638232,0.0148516744882505,0.4201328921236
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,36991,-0.00810974021363368,0.00537247736037428,-0.0186397958399673,0.00242031541269991,0.131195798530378
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,36991,-0.00549652376214471,0.00526753361910567,-0.0158208896555918,0.00482784213130241,0.296748958914533
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,36991,-0.00932550040872569,0.00589184808005337,-0.0208735226456303,0.00222252182817891,0.113495657217961
TFAP2A,Transcription factor AP-2-alpha,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,36991,0.00895255417673771,0.00592085963417693,-0.00265233070624907,0.0205574390597245,0.130548715428977
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47287,0.0015184382332333,0.00452647883585339,-0.00735346028503935,0.0103903367515059,0.737283509788554
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47287,0.00499632353248441,0.00442877032082442,-0.00368406629633145,0.0136767133613003,0.259267529012286
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45569,-0.000977206830326194,0.00427965770259291,-0.00936533592740829,0.0074109222667559,0.819385935376436
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45569,0.00109729748427597,0.00463143889686429,-0.00798032275357804,0.01017491772213,0.812718244976147
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45569,0.00104877032188804,0.00460243863028687,-0.00797200939347423,0.0100695500372503,0.819747318136069
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45569,-0.00463542614952083,0.00424355101312894,-0.0129527861352536,0.0036819338362119,0.274693152476047
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24009.Traffic intensity on the nearest road,47287,0.0362639126136026,0.0432034727499006,-0.0484148939762025,0.120942719203408,0.401267503962401
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24010.Inverse distance to the nearest road,47287,-0.00452499458350066,0.00396748292725939,-0.0123012611209291,0.00325127195392774,0.254081284361471
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24011.Traffic intensity on the nearest major road,47287,-0.00181565210118951,0.0040061275958545,-0.00966766218906434,0.00603635798668532,0.650395437072695
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24012.Inverse distance to the nearest major road,47287,0.00640971149393937,0.00405756080917343,-0.00154310769204056,0.0143625306799193,0.114190064200879
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24013.Total traffic load on major roads,47287,0.0229643460555518,0.0303908517433965,-0.0366017233615052,0.0825304154726089,0.449876554813325
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24015.Sum of road length of major roads within 100m,47287,0.0157745063527221,0.0297186688499349,-0.0424740845931503,0.0740230972985945,0.595566214779979
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47287,-0.000410843623449093,0.00454988848867031,-0.00932862506124289,0.00850693781434471,0.92805156689124
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47287,-6.45641735316801e-05,0.00454851731837119,-0.00897965811753922,0.00885052977047586,0.988674885905095
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47287,0.00107981129186092,0.00450309643654583,-0.00774625772376891,0.00990588030749075,0.810492782211409
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47242,0.0028756102877926,0.00435712093358576,-0.00566434674203549,0.0114155673176207,0.50927351620034
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24020.Average daytime sound level of noise pollution,47287,-0.0017192141042348,0.00397766706666514,-0.00951544155489848,0.00607701334642887,0.665587906312725
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24021.Average evening sound level of noise pollution,47287,-0.00175385697851965,0.00397719344003922,-0.00954915612099651,0.00604144216395721,0.659232598376231
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24022.Average night-time sound level of noise pollution,47287,-0.00173045546349603,0.00397778438225844,-0.00952691285272257,0.00606600192573051,0.663544673188422
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47287,-0.00173769811882765,0.00397758024775084,-0.00953375540441928,0.00605835916676399,0.662207352244872
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47287,-0.00177381421949451,0.00397779039088847,-0.00957028338563591,0.00602265494664688,0.65565226798711
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2405.Number of children fathered,34303,-0.00838026939095839,0.0336401810528526,-0.0743150242545495,0.0575544854726327,0.803276825137101
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44478,-0.00611050165009032,0.00469087665288006,-0.0153046198897352,0.00308361658955461,0.192713839799525
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44478,0.00735193172297272,0.00427377823771698,-0.00102467362295257,0.015728537068898,0.0854035135136666
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24502.Water percentage, buffer 1000m",44478,-0.000725238442421233,0.0041623988894233,-0.00888354026569091,0.00743306338084844,0.861681948618131
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44478,-0.0064378550592902,0.00442631654746578,-0.0151134354923231,0.00223772537374273,0.145836874021214
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44478,0.0058194109081294,0.0043403619233967,-0.00268769846172814,0.0143265202779869,0.180011118898566
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24505.Water percentage, buffer 300m",44478,0.00235766779753517,0.00418528721750857,-0.00584549514878163,0.010560830743852,0.573221207745594
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47365,-0.00686252184357205,0.00444457578665957,-0.0155738903854248,0.00184884669828071,0.122596517302663
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47365,-0.00680975663401114,0.00418925394518926,-0.0150206943665821,0.00140118109855981,0.104063151061297
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X24508.Distance (Euclidean) to coast,47365,-0.000608318641900811,0.00401048679505104,-0.00846887276020085,0.00725223547639923,0.879439059752123
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,27953,-0.075565585750641,0.0503575329213947,-0.174266350276575,0.0231351787752927,0.133540953195816
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2704.Years since last cervical smear test,33774,0.00415883575942736,0.0302568864012261,-0.0551446615869758,0.0634623331058305,0.89067720492843
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2714.Age when periods started (menarche),36604,0.0235436262606354,0.0271397585990521,-0.0296503005935067,0.0767375531147775,0.385686752743889
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2734.Number of live births,37007,-0.0364848618430227,0.025897231549649,-0.0872434356803348,0.0142737119942894,0.158908360646178
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2744.Birth weight of first child,33748,-0.00935143246485675,0.0300962340870336,-0.0683400512754426,0.0496371863457291,0.756021799066172
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2754.Age at first live birth,32051,-0.0125263783318929,0.0065000150305291,-0.0252664077917299,0.000213651127944173,0.0539978888743516
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2764.Age at last live birth,32029,-0.004599011534428,0.00650376254892453,-0.0173463861303201,0.00814836306146409,0.479505296609468
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2794.Age started oral contraceptive pill,35053,0.0135393679467125,0.00675681275330822,0.000296014950228353,0.0267827209431966,0.0451144859252631
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2804.Age when last used oral contraceptive pill,34034,-0.00354271826160855,0.00594779856038571,-0.0152004034399645,0.00811496691674745,0.551432195455989
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2867.Age started smoking in former smokers,28478,0.0126015175451049,0.00879708577115926,-0.00464077056636729,0.029843805656577,0.152078469993941
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34123,-0.0406221329034567,0.0358870172037261,-0.11096068662276,0.0297164208158464,0.257683972372692
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34118,-0.0566785169248116,0.0399765851346339,-0.135032623788694,0.0216755899390708,0.156281630225879
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34133,0.00647380604731523,0.0397738315878588,-0.0714829038648881,0.0844305159595186,0.870706305473004
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34109,-0.050487948837154,0.039987727144186,-0.128863894039758,0.0278879963654506,0.206766694367922
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28739.Difficulty with standing for long periods,34149,-0.00102970098696311,0.0368118165047663,-0.073180861336305,0.0711214593623788,0.977685007281534
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28740.Difficulty with taking care of household responsibilities,34166,0.0142601441420655,0.0407019392897793,-0.065515656865902,0.0940359451500329,0.72607915706875
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28741.Difficulty learning a new task,34090,0.0258722427679118,0.0456390070252079,-0.0635802110014956,0.115324696537319,0.570802162631922
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28742.Difficulty with joining in community activities,33714,0.0483122027586031,0.0431213169785399,-0.0362055785193351,0.132829984036541,0.262579753716467
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28743.Difficulty with being emotionally affected by health problems,34094,-0.0251309556164651,0.0390650236798653,-0.101698402029001,0.0514364907960709,0.520036801947991
TFAP2A,Transcription factor AP-2-alpha,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34164,-0.0152530605176806,0.0521710253164819,-0.117508270137985,0.0870021491026239,0.770012300610385
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28352,0.00907874285867286,0.0485690730647695,-0.0861166403482753,0.104274126065621,0.851728383367942
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2897.Age stopped smoking,28481,0.00189623858631315,0.010607397400243,-0.0188942603181632,0.0226867374907895,0.858129533023159
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33007,-0.0147465176480392,0.0133466199977739,-0.040905892843676,0.0114128575475977,0.269237269962926
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33007,-0.00735995023423207,0.0143170272124891,-0.0354213235707106,0.0207014231022465,0.607215662178107
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33007,-0.0149001107279845,0.0482241495774864,-0.109419443899858,0.0796192224438889,0.757346727541566
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33007,0.0543154331784235,0.0475906329074886,-0.0389622073202542,0.147593073677101,0.253772848843533
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33007,-0.0270860239908621,0.0504846308981164,-0.12603590055117,0.0718638525694461,0.591612130720906
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33007,-0.0152006027521744,0.0428154201997969,-0.0991188263437764,0.0687176208394275,0.72257802948529
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33007,0.0194428823665344,0.019865428024526,-0.0194933565615364,0.0583791212946053,0.327739488374054
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33007,-0.0103752177271346,0.0360401019230784,-0.0810138174963682,0.060263382042099,0.773445263685182
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29002.Recent lack of interest or pleasure in doing things,32956,-0.0194228013847905,0.0409717849908013,-0.099727499966761,0.0608818971971799,0.635473428323534
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29003.Recent feelings of depression,32955,-0.0493608758774215,0.0399000364881222,-0.127564947394141,0.028843195639298,0.216076876450267
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32963,-0.0109707186159371,0.0322672330998719,-0.0742144954916861,0.0522730582598119,0.733867656510109
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29005.Recent feelings of tiredness or low energy,32967,-0.00596363763413266,0.0329215324255822,-0.0704898411882738,0.0585625659200085,0.856256207065782
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29006.Recent poor appetite or overeating,32970,0.0185595808682966,0.0431537450320941,-0.0660217593946077,0.103140921131201,0.667147316313756
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29007.Recent feelings of inadequacy,32941,-0.0180906457702939,0.042306885652609,-0.101012141649407,0.0648308501088197,0.668948695639557
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29008.Recent trouble concentrating on things,32970,-0.0148979035944247,0.0425775778840457,-0.0983499562471543,0.0685541490583049,0.726421677129158
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32959,0.0808122599549732,0.0705606742709759,-0.0574866616161397,0.219111181526086,0.252120201094148
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29010.Recent thoughts of suicide or self-harm,32909,0.0370579064322097,0.0789732190007894,-0.117729602809337,0.191845415673757,0.638904760961162
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29038#0.Substances taken for depression_None of options listed,31342,0.0237347399909384,0.0245390470888829,-0.0243617923032721,0.0718312722851489,0.333463641091211
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31342,0.0157084569631635,0.0430980378524798,-0.068763697227697,0.100180611154024,0.71550844894975
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31342,0.0126222286665479,0.0243955319909249,-0.0351930140356648,0.0604374713687606,0.604892815568915
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31342,-0.0591955429449421,0.0715564197781686,-0.199446125710153,0.0810550398202683,0.408117842209018
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31342,-0.00165178531173723,0.0419819877598034,-0.0839364813209519,0.0806329106974774,0.968616303273863
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31342,-0.00133964807265882,0.0449303330495592,-0.0894031008497949,0.0867238047044772,0.976214500116237
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31342,-0.00449734813955768,0.0537661350462866,-0.109878972830279,0.100884276551164,0.933339745500269
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31342,0.0771329693536626,0.061116684798006,-0.0426557328504291,0.196921671557754,0.206966264630263
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31342,0.0376605894292425,0.0489561406803236,-0.0582934463041919,0.133614625162677,0.44175612484801
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31342,0.0258698906787259,0.0250051200574732,-0.0231401446339216,0.0748799259913735,0.300896787321552
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31342,-0.039249180196035,0.0365823532711217,-0.110950592607434,0.0324522322153635,0.283350915269183
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31342,0.0196529449048908,0.0583360706229138,-0.0946857535160203,0.133991643325802,0.736207902272143
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31342,0.113045704968016,0.0715115633188891,-0.0271169591370062,0.253208369073039,0.113965322577555
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31342,0.0492408748354132,0.0454138455206971,-0.0397702623851531,0.138252012055979,0.278279995201317
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31342,-0.0124480125184368,0.0730714251878781,-0.155668005886678,0.130771980849804,0.86473632026237
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31342,-0.0388353325732646,0.0696463917579983,-0.175342260418941,0.0976715952724121,0.577129290477671
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31342,0.0700851892957823,0.0377858117911685,-0.00397500181490792,0.144145380406473,0.0636638567406641
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31342,0.0250566068127298,0.0375174974093857,-0.0484776881096662,0.0985909017351258,0.50424065285912
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31342,-0.000731480205485884,0.0541032457062045,-0.106773841789647,0.105310881378675,0.989213226086556
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29058.Recent feelings or nervousness or anxiety,32820,-0.0151903197775109,0.0373449327878954,-0.0883863880417859,0.0580057484867641,0.684196052479451
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29059.Recent inability to stop or control worrying,32823,-0.0313548043604761,0.0395769655101193,-0.10892565676031,0.0462160480393577,0.428236577671909
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29060.Recent worrying too much about different things,32817,-0.020481027744104,0.0361657202992061,-0.091365839530548,0.0504037840423399,0.571196904058088
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29061.Recent trouble relaxing,32821,-0.0225669106272647,0.0378866789280816,-0.0968248013263046,0.0516909800717753,0.551429222047459
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29062.Recent restlessness,32825,0.0651283404323889,0.0508405618500034,-0.0345191607936178,0.164775841658396,0.200215889343541
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29063.Recent easy annoyance or irritability,32812,-0.0105045112867512,0.0385822602450983,-0.0861257413671438,0.0651167187936415,0.785426296126796
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29064.Recent feelings of foreboding,32804,-0.0790398420578108,0.0451351695661915,-0.167504774407546,0.00942509029192458,0.0799490575337527
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31342,-0.00928384800260224,0.0250403506848656,-0.0583629353449389,0.0397952393397344,0.710830136874004
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31342,0.0341600747769822,0.0405140354432424,-0.0452474346917728,0.113567584245737,0.399162322043106
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31342,0.0190933210274698,0.0550149161444941,-0.0887359146157386,0.126922556670678,0.728558131346903
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31342,0.0595208548370079,0.0594504127609943,-0.057001954174541,0.176043663848557,0.316769808796593
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#2.Symptoms of panic attack_Sweating,31342,-0.0624325584092581,0.0382061552755181,-0.137316622749274,0.0124515059307575,0.10228058556154
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31342,-0.0176639055594611,0.0405208724617819,-0.0970848155845536,0.0617570044656315,0.662906511480885
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31342,0.0874774872394775,0.0410450982851504,0.00702909460058275,0.167925879878372,0.0331008090254906
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31342,-0.0349822660708537,0.0377123974707354,-0.108898565113495,0.0389340329717877,0.353641632069165
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31342,-0.0418318392167144,0.0495470545368575,-0.138944066108955,0.0552803876755262,0.398537111612853
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29076.Felt loved as a child,32786,-0.0677234780165058,0.0329003021058823,-0.132208070144035,-0.00323888588897654,0.0395763597416049
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29077.Physically abused by family as a child,32789,-0.00948216694065931,0.0430166463045347,-0.0937947936975473,0.0748304598162287,0.825541187112315
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29078.Felt hated by family member as a child,32777,0.0155853210976449,0.0431810278343595,-0.0690494934576997,0.10022013565299,0.718160455347976
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29079.Sexually molested as a child,32717,-0.0946066556353584,0.0620433681285702,-0.216211657167356,0.0269983458966391,0.12733293258175
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29080.Someone to take to doctor when needed as a child,32776,-0.0306494046416798,0.0502451001463456,-0.129129800928517,0.0678309916451576,0.541878762067543
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32774,-0.0893482409901989,0.0632118237969553,-0.213243415632231,0.0345469336518335,0.15755145598895
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32731,-0.00948710367536035,0.0474892677628812,-0.102566068490608,0.0835918611398868,0.841662200873548
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32781,-0.0160880173901461,0.0528815908493296,-0.119735935454832,0.0875599006745399,0.760961913692052
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32750,-0.0500608073271036,0.0756122810569502,-0.198260878198726,0.0981392635445187,0.507941961509774
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32748,-0.0424005001831081,0.0730387531658372,-0.185556456388149,0.100755456021933,0.561578324163546
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29086.Experienced a violent or sexual assault,32784,-0.0875241905207462,0.0603769061995353,-0.205862926671835,0.0308145456303429,0.147196796192898
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29087.Experienced a life-threatening injury or illness,32792,0.0611343106960604,0.0404413361159921,-0.0181307080912841,0.140399329483405,0.130650973759568
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29088.Experienced a marital separation or divorce,32792,0.00268818938732426,0.0365293843108997,-0.0689094038620391,0.0742857826366876,0.941338450777534
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29089.Experienced the death of a spouse or partner,32799,0.0629132816260451,0.0565315164989644,-0.0478884907119252,0.173715053964015,0.26578619571369
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32788,0.0145705220121425,0.0452838423658611,-0.0741858090249452,0.10332685304923,0.747642171940453
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29091.Frequency of drinking alcohol,32795,-0.0762788352854821,0.0306060147076383,-0.136266624112453,-0.0162910464585111,0.0127104866779121
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31870,-0.0542454208196269,0.0347712004227824,-0.12239697364828,0.0139061320090265,0.11878344410765
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31883,-0.090440622738372,0.0348523737960712,-0.158751275378671,-0.0221299700980726,0.00947733355008776
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29104.Ever used cannabis,32784,-0.0724907833075818,0.0417988533734659,-0.154416535919575,0.00943496930441137,0.0829035182870492
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29108.Ever thought that life not worth living,32751,0.00751986527668937,0.0369751276919209,-0.0649513849994755,0.0799911155528543,0.83884556428619
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29109.Ever contemplated self-harm,32757,-0.0315463052074313,0.0492671547594018,-0.128109928535859,0.0650173181209963,0.521986868351993
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29111.Ever self-harmed,32777,-0.00161378932580134,0.0759776181606199,-0.150529920920616,0.147302342269014,0.983054421881242
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32783,0.0707067540987274,0.0500903883711562,-0.0274704071087387,0.168883915306194,0.158107573935216
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31861,0.0589875299841093,0.0507697150595589,-0.0405211115326261,0.158496171500845,0.245325163679414
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31861,0.0354575236366468,0.0401803219617181,-0.0432959074083207,0.114210954681614,0.377554656933314
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31861,0.0726559321387562,0.0417015553673139,-0.00907911638117911,0.154390980658691,0.0814972713874849
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31861,0.0870266015873694,0.055026639950826,-0.0208256127162496,0.194878815890988,0.113795104403565
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32773,-0.00122416067544422,0.0343373455999013,-0.0685253580512507,0.0660770367003623,0.971561441227685
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X29153.Pain or discomfort today,32786,0.025776973591047,0.0327888134491343,-0.0384891007692563,0.0900430479513503,0.431799634980063
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29154.Anxiety or depression today,32786,-0.0109660438047698,0.0403925722466604,-0.0901354854082241,0.0682033977986845,0.786023052583663
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29166.Frequency of confiding in someone close,32587,0.00185204828737054,0.0321241808517912,-0.0611113461821402,0.0648154427568813,0.954026528810709
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32757,-0.00152164684821017,0.0139527275171619,-0.0288689927818475,0.0258256990854272,0.913159498653912
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32757,0.00526102636541556,0.0138651745392333,-0.0219147157314818,0.0324367684623129,0.704368893528585
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32757,-0.0171371355265443,0.0173555368747987,-0.0511539878011498,0.0168797167480612,0.32346557504615
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32757,-0.00144100282764425,0.0204077428325891,-0.0414401787795189,0.0385581731242304,0.943709266292876
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32757,-0.00317512683297557,0.0319365853943731,-0.0657708342059468,0.0594205805399956,0.920807254613884
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32757,-0.00431276661079734,0.0149414768206921,-0.0335980611793539,0.0249725279577592,0.77286059771171
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32754,0.0207487112243955,0.0162932486470566,-0.0111860561238355,0.0526834785726265,0.202890079928961
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32754,-0.0186623889702683,0.0231604005260346,-0.064056774001296,0.0267319960607595,0.420386238897157
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32754,-0.0399393249292945,0.0374133736988793,-0.113269537379098,0.0333908875205089,0.285768471469624
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32754,0.0257372122261942,0.0369665920522644,-0.046717308196244,0.0981917326486324,0.48630364269847
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32754,-0.0421112882260016,0.0489747404825669,-0.138101779571833,0.0538792031198295,0.389890883540808
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32754,-0.0369020197518517,0.0240254244248395,-0.0839918516245371,0.0101878121208338,0.12458448856762
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29171.Frequency of feeling 'in tune' with people,32597,0.0053834817039496,0.0392030257185716,-0.0714544487044508,0.08222141211235,0.890778563106623
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29172.Freuency of feeling that lacks companionship,32715,-0.0889059103048061,0.0364705604120445,-0.160388208712413,-0.0174236118971989,0.0147987537853483
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29173.Frequency of feeling left out,32672,-0.0183619792639759,0.0366112336080962,-0.0901199971358444,0.0533960386078927,0.616004026828949
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29174.Frequency of feeling isolated from others,32700,-0.0160784800966685,0.0378021721314197,-0.0901707374742512,0.0580137772809141,0.670604896109368
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29175.Tendency to bounce back quickly after hard times,32771,-0.0046736698657215,0.0319822592197964,-0.0673588979365224,0.0580115582050794,0.883819544955143
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29176.Ability to make it through stressful events,32771,-0.0420960930641493,0.0308255239813875,-0.102514120067669,0.0183219339393703,0.17209130940985
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29177.Quick recovery from stressful events,32771,0.0403759621428259,0.0318546069179484,-0.022059067416353,0.102810991702005,0.205006914764074
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29178.Hard to snap back when something bad happens,32771,-0.00382143837004607,0.0317447263109951,-0.0660411019395964,0.0583982251995043,0.90418464371641
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29179.Comes through difficult times with little trouble,32771,0.0344824582747175,0.031866630228336,-0.0279761369728211,0.096941053522256,0.279243274464181
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29180.Tendency to take a long time to get over setbacks,32771,0.00131927007937939,0.0317540711572766,-0.0609187093888827,0.0635572495476415,0.966861165302325
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29181.General happiness,32714,-0.0665528450515513,0.0326450527605171,-0.130537148462165,-0.00256854164093781,0.0415115441704457
TFAP2A,Transcription factor AP-2-alpha,Mental health,X29182.Belief that own life is meaningful,32632,0.0144139553861217,0.032293497961733,-0.048881300618875,0.0777092113911184,0.655360999048678
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28088,-0.0122873410332442,0.0476511820640301,-0.105683657878743,0.0811089758122549,0.796527392144123
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2946.Father's age,32426,0.00517599435175738,0.00972961074170424,-0.0138940427019829,0.0242460314054977,0.594751079242088
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X2966.Age high blood pressure diagnosed,28257,-4.93514765671459e-05,0.0164170333777462,-0.0322267368969496,0.0321280339438153,0.997601607902986
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30000.White blood cell (leukocyte) count,46871,0.0012716979512942,0.00415775990136761,-0.00687751145538633,0.00942090735797472,0.759713000899132
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46871,0.0133844923252491,0.00491036747855089,0.00376017206728933,0.0230088125832088,0.00642017937025736
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30020.Haemoglobin concentration,46871,0.00131500551117935,0.00523687917208355,-0.0089492776661044,0.0115792886884631,0.801735324970094
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30030.Haematocrit percentage,46871,0.00107016580422264,0.00514052336886412,-0.00900525999875104,0.0111455916071963,0.835088497263404
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30040.Mean corpuscular volume,46871,-0.0176453343512976,0.00414992360484571,-0.0257791846167951,-0.00951148408579996,2.1273733643701e-05
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46870,-0.0137520999158581,0.00416197596543728,-0.0219095728081152,-0.00559462702360106,0.000953852054540473
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46870,-0.000311723507650649,0.00407300912610735,-0.00829482139482105,0.00767137437951975,0.938994964349497
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46871,0.0106593346187314,0.00395896190171277,0.00289976929137441,0.0184188999460885,0.00709790194412036
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30080.Platelet count,46871,0.00652998947722838,0.00418452386188736,-0.00167167729207084,0.0147316562465276,0.118653265268493
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30090.Platelet crit,46871,0.0101829033199505,0.00428902760252996,0.00177640921899179,0.0185893974209092,0.0175963542694092
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46871,0.00379767783308745,0.00403937904735875,-0.0041195050997357,0.0117148607659106,0.347143431420238
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30110.Platelet distribution width,46871,0.00607867218040079,0.00400323039409382,-0.00176765939202309,0.0139250037528247,0.128916810712455
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30120.Lymphocyte count,46839,-0.00581451809338069,0.00422889252814283,-0.0141031474485406,0.00247411126177924,0.169160182628816
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30130.Monocyte count,46839,0.00658201823705114,0.0042290377328286,-0.0017068957192929,0.0148709321933952,0.119629928667814
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30140.Neutrophill count,46839,0.00145029591079476,0.00412066738065619,-0.00662621215529137,0.00952680397688089,0.724874069120678
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30150.Eosinophill count,46839,0.00712162125957151,0.00402632229231826,-0.000769970433372277,0.0150132129525153,0.0769462262816338
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30160.Basophill count,46839,0.0107185212278436,0.0219939896568848,-0.0323896984996507,0.0538267409553378,0.626023011260217
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30170.Nucleated red blood cell count,46839,0.0695397457761539,0.0920370961164207,-0.110852962612031,0.249932454164338,0.449919504194504
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30180.Lymphocyte percentage,46839,-0.007499820327929,0.00416037605644113,-0.0156541573985536,0.000654516742695618,0.0714518229047691
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30190.Monocyte percentage,46839,0.00774707066971899,0.00416983975394901,-0.000425815248021076,0.0159199565874591,0.0631985388462791
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30200.Neutrophill percentage,46839,0.00206269018935173,0.0040948203749196,-0.00596315774549068,0.0100885381241941,0.614454867711169
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30210.Eosinophill percentage,46839,0.00698148350245278,0.00396976376636306,-0.000799253479618805,0.0147622204845244,0.0786477813643608
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30220.Basophill percentage,46839,0.00259133828692935,0.00396246135825283,-0.00517508597524619,0.0103577625491049,0.513136469533714
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30230.Nucleated red blood cell percentage,46839,0.0682004033568993,0.0920912697315042,-0.112298485316849,0.248699292030648,0.458959322439367
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30240.Reticulocyte percentage,46446,-0.00833431682712137,0.00426682144899719,-0.0166972868671559,2.8653212913116e-05,0.0507982054121491
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30250.Reticulocyte count,46446,-0.00595314723636045,0.00438080068553189,-0.014539516580003,0.00263322210728206,0.174186264724177
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30260.Mean reticulocyte volume,46446,-0.0100521163265207,0.00411784952301471,-0.0181231013916296,-0.0019811312614119,0.0146498910190589
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30270.Mean sphered cell volume,46446,-0.0127727547283071,0.00413477317353701,-0.0208769101484397,-0.00466859930817457,0.00201003132406968
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30280.Immature reticulocyte fraction,46446,-0.00974340171949228,0.00430571620481784,-0.0181826054809353,-0.00130419795804931,0.0236513575637079
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46446,-0.0114729221836886,0.00436383408226742,-0.0200260369849327,-0.00291980738244441,0.00856711202198306
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30300.High light scatter reticulocyte count,46446,-0.00997849855809115,0.00444272357805161,-0.0186862367710723,-0.00127076034510999,0.0247115947185759
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30500.Microalbumin in urine,30760,0.0103514286807406,0.00755753486460639,-0.00446133965388796,0.0251641970153691,0.170830380442222
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,46984,-0.00102921389639664,0.0042283666449065,-0.00931681252041338,0.0072583847276201,0.807692307066503
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30520.Potassium in urine,46937,-0.00249078490042845,0.00391555139310847,-0.010165265630921,0.00518369583006415,0.524700466725846
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30530.Sodium in urine,46934,-0.00635953946812671,0.0040791930976503,-0.0143547579395213,0.00163567900326788,0.119005602233274
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30600.Albumin,44605,0.00124606175734034,0.00441563152954795,-0.00740857604057365,0.00990069955525433,0.77779808897027
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30610.Alkaline phosphatase,46530,0.00895408270810684,0.00415510028556894,0.000810086148391719,0.017098079267822,0.0311753145204715
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30620.Alanine aminotransferase,46521,0.00250233247600395,0.00440272946710432,-0.00612701727952052,0.0111316822315284,0.569796615705891
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30630.Apolipoprotein A,44477,-0.0165098711901182,0.00482077919069261,-0.0259585984038757,-0.00706114397636071,0.000616606779854736
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30640.Apolipoprotein B,46382,-0.00625758307263308,0.00422798372269571,-0.0145444311691167,0.00202926502385051,0.138876683089369
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30650.Aspartate aminotransferase,46457,0.00762086489924054,0.00411401851613658,-0.000442611392387153,0.0156843411908682,0.0639794485784874
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30660.Direct bilirubin,42943,0.00278981432541957,0.00459423119044666,-0.00621487880785588,0.011794507458695,0.543696943202898
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30670.Urea,46525,0.00255549919543192,0.00434475116532739,-0.00596021308860976,0.0110712114794736,0.556416807086469
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30680.Calcium,44602,0.00253518264189434,0.00430656722690778,-0.00590568912284491,0.0109760544066336,0.556083512624487
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30690.Cholesterol,46535,-0.00841562244349288,0.00434060288432168,-0.0169232040967634,9.19592097776215e-05,0.0525363600444046
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30700.Creatinine,46529,-0.00646585599350498,0.00529026571002377,-0.0168347767851516,0.00390306479814161,0.221638048366612
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30710.C-reactive protein,46463,0.00530750188517567,0.00450574581599468,-0.00352375991417391,0.0141387636845253,0.238832604976327
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30720.Cystatin C,46533,0.0083813477885693,0.00488338074052837,-0.00119007846286631,0.0179527740400049,0.0861207546289864
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30730.Gamma glutamyltransferase,46526,0.00660128582756821,0.00448773911111831,-0.00219468283022368,0.0153972544853601,0.141315750203311
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30740.Glucose,44569,0.000645704843587989,0.00438621219742296,-0.00795127106336101,0.00924268075053699,0.882965803083807
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46356,0.00164491521576235,0.00439248638690999,-0.00696435810258123,0.0102541885341059,0.708047899162617
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30760.HDL cholesterol,44583,-0.0121014713359272,0.00509697902911966,-0.0220915502330017,-0.00211139243885265,0.0175939858487682
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30770.IGF-1,46425,-0.00565238424239896,0.00427749684479987,-0.0140362780582067,0.0027315095734088,0.186373639922404
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30780.LDL direct,46485,-0.00597359151539764,0.00428883438631662,-0.0143797069125782,0.00243252388178294,0.163686701192955
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30790.Lipoprotein A,42018,-0.00429690827528482,0.0045047263653873,-0.0131261719514439,0.00453235540087429,0.340163841159025
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30810.Phosphate,44551,0.00302147015192414,0.0042990915328649,-0.00540474925249106,0.0114476895563393,0.482178355386389
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30830.SHBG,44401,0.00135710350257028,0.00499958768887652,-0.0084420883676277,0.0111562953727683,0.786052996725821
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30840.Total bilirubin,46449,-0.000989145505819355,0.00420593141194197,-0.00923277107322561,0.0072544800615869,0.814072164714447
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30850.Testosterone,44707,-0.00282977010640849,0.0070854115843145,-0.0167171768116649,0.0110576365988479,0.689617483070704
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30860.Total protein,44590,0.0209348835953016,0.00437756543230097,0.0123548553479917,0.0295149118426115,1.74480835437544e-06
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30870.Triglycerides,46518,-0.000895049980627854,0.00430579186528341,-0.00933440203658333,0.00754430207532762,0.835331430939426
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30880.Urate,46507,0.000177564489626159,0.0052180838570982,-0.0100498798702863,0.0104050088495386,0.972854582967443
TFAP2A,Transcription factor AP-2-alpha,Blood and urine assays,X30890.Vitamin D,45598,0.00318730896447834,0.004517293951437,-0.00566658718033818,0.0120412051092949,0.480457380856567
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X3137.Number of measurements made,45662,0.0138952279587223,0.0252980925006011,-0.035689033342456,0.0634794892599005,0.582832722555857
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X3143.Ankle spacing width,37263,0.00152628969150043,0.00748056648873443,-0.0131356206264191,0.0161882000094199,0.8383300494418
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37262,-0.00527066872064143,0.00571196249500713,-0.0164661152108554,0.00592477776957254,0.356158190671362
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X3146.Speed of sound through heel,37263,0.00141113430460556,0.0055656293584354,-0.00949749923792783,0.0123197678471389,0.799851423779889
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37263,-0.000863691447435652,0.00561470541213547,-0.0118685140552212,0.0101411311603499,0.877748718893093
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X3148.Heel bone mineral density (BMD),37254,-0.0010623662997636,0.00562727124199806,-0.0120918179340798,0.0099670853345526,0.850261138911005
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X3526.Mother's age at death,33473,0.00320512714209783,0.00757938631494591,-0.0116504700351962,0.0180607243193918,0.672396485460217
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X3581.Age at menopause (last menstrual period),29357,-0.000729499495970644,0.0100848323443535,-0.0204957708909035,0.0190367718989622,0.942336905312898
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29277,0.00340716838827371,0.0094579340338369,-0.0151303823180466,0.021944719094594,0.718678370240698
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4100.Ankle spacing width (left),31472,0.000650727572420754,0.00969839762128849,-0.0183581317653047,0.0196595869101462,0.946506721473439
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31472,0.00748474388313766,0.00740099463278333,-0.00702120559711767,0.021990693363393,0.311897381387165
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4103.Speed of sound through heel (left),31472,0.0134200781307183,0.00723062882323688,-0.000751954362825958,0.0275921106242626,0.0634915651621375
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31472,0.0116241219969713,0.00729427140408622,-0.00267264995503772,0.0259208939489803,0.111068061543265
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4105.Heel bone mineral density (BMD) (left),31466,0.0118094007330359,0.00730508423274161,-0.00250856436313765,0.0261273658292095,0.106006076615133
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31472,0.0116462185368407,0.00729431856421524,-0.00265064584902114,0.0259430829227026,0.110393060246206
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4119.Ankle spacing width (right),31463,0.00330784235198147,0.00953592067994468,-0.0153825621807101,0.021998246884673,0.728689324866568
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31463,0.0161950332951319,0.00749283962409041,0.00150906763191474,0.0308809989583491,0.0306954679080758
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4122.Speed of sound through heel (right),31463,0.0197224828794441,0.00728271030336589,0.00544837068484699,0.0339965950740413,0.00678161138755421
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31463,0.018783778346299,0.00736130629513005,0.00435561800784406,0.0332119386847539,0.010739553549581
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4124.Heel bone mineral density (BMD) (right),31456,0.0196735620692772,0.00737515877167199,0.00521825087680006,0.0341288732617543,0.00765699293155813
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31463,0.0187834628610111,0.00736135357917222,0.00435520984583355,0.0332117158761886,0.0107413781694871
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4194.Pulse rate,31727,0.000462227531492364,0.00707390412676426,-0.0134026245569656,0.0143270796199503,0.947902857762466
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4195.Pulse wave reflection index,31727,-0.00935760860805552,0.00688923342692231,-0.0228605061248232,0.0041452889087122,0.17440917018317
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4196.Pulse wave peak to peak time,31722,0.00754738611730752,0.00737314425330786,-0.00690397661917589,0.0219987488537909,0.306040637458031
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4198.Position of the pulse wave peak,31727,-0.00648661892581141,0.00709556058948874,-0.0203939176812093,0.00742067982958652,0.360650336884044
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4199.Position of pulse wave notch,31727,0.00108076958568797,0.00697912388252285,-0.0125983132240568,0.0147598523954327,0.876937642388749
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4200.Position of the shoulder on the pulse waveform,31727,-0.00958653470378439,0.00726433612848664,-0.0238246335156182,0.00465156410804942,0.186983242690148
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4269.Number of triplets attempted (left),31593,-0.167153193542203,0.108335472802269,-0.37949072023465,0.0451843331502434,0.12289067428813
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4270.Volume level set by participant (left),31514,0.0318891968960649,0.0344505932548917,-0.0356339658835227,0.0994123596756525,0.354657015861916
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4276.Number of triplets attempted (right),31604,-0.173540270084336,0.105299853787357,-0.379927983507557,0.0328474433388838,0.0993813982581949
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X4277.Volume level set by participant (right),31516,-0.00336907037853291,0.0350038556362752,-0.0719766274256323,0.0652384866685664,0.923325691944101
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X4288.Time to answer,31747,-0.00717725297697555,0.00806223385513691,-0.0229792313330439,0.0086247253790928,0.373368851484333
TFAP2A,Transcription factor AP-2-alpha,Cognitive function,X4290.Duration screen displayed,31747,-0.000371221231813749,0.00705788376406056,-0.0142046734093724,0.0134622309457449,0.958054596815474
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X46.Hand grip strength (left),47567,-0.00197465666324413,0.00566118506700317,-0.0130705793945703,0.00912126606808208,0.727237877928808
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X47.Hand grip strength (right),47548,-0.00328168845583499,0.00561049473404271,-0.0142782581345587,0.00771488122288871,0.558607335658781
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X48.Waist circumference,47618,0.00169040781444015,0.00887315766184565,-0.0157009812027773,0.0190817968316576,0.848912676608918
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X4803.Tinnitus,31552,0.0689423534286752,0.0421577171368821,-0.0136867721596137,0.151571479016964,0.102017968198277
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X4825.Noisy workplace,31682,0.0101536252291751,0.0482539711712929,-0.0844241582665591,0.104731408724909,0.833344968423009
TFAP2A,Transcription factor AP-2-alpha,Working and living environment,X4836.Loud music exposure frequency,31629,-0.0635950158023402,0.0526680644654792,-0.166824422154679,0.039634390549999,0.227288631994567
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X49.Hip circumference,47614,-0.00675178629263414,0.00700524996884296,-0.0204820762315663,0.00697850364629806,0.335146972223107
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X50.Standing height,47590,0.00292872759441927,0.00557053895983734,-0.00798952876686191,0.0138469839557004,0.599064743784408
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X5057.Number of older siblings,31030,-0.00587596739478901,0.0372199150178822,-0.0788270008298381,0.06707506604026,0.874562426573726
TFAP2A,Transcription factor AP-2-alpha,Physical measures,X51.Seated height,47479,-0.00166713736342376,0.00515412107515946,-0.0117692146707363,0.00843493994388878,0.746351910515298
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5181.Ever had eye surgery,29200,-0.0670502960002249,0.096687634103508,-0.256558058843101,0.122457466842651,0.488042727386028
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5186.Duration visual-acuity screen displayed (right),29190,-0.00107547018870685,0.00876142054755566,-0.0182478544619159,0.0160969140845022,0.902309171180937
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5188.Duration visual-acuity screen displayed (left),29189,0.00959635402425409,0.00866256126152221,-0.00738226604832943,0.0265749740968376,0.267999760507291
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5190.Duration at which refractometer first shown (right),29138,0.00595453985996986,0.00847728524267128,-0.0106609392156658,0.0225700189356056,0.482453755938443
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5193.Duration at which refractometer first shown (left),29137,0.00536646802760599,0.00851514118487625,-0.0113232086947515,0.0220561447499634,0.528573661325911
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5199.logMAR, initial (right)",29167,-0.0012590359182969,0.0422727934191912,-0.0841137110199116,0.0815956391833178,0.97624075938578
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5200.Final number of letters displayed (right),29167,0.40368999877826,0.385455114341513,-0.351802025331106,1.15918202288763,0.295005531085227
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5201.logMAR, final (right)",29121,-0.00265057130857134,0.00819523433277745,-0.0187132306008151,0.0134120879836725,0.746383699474668
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5202.Number of rounds to result (right),29167,-0.00793891021855278,0.0412532652461644,-0.088795310101035,0.0729174896639294,0.847402437619177
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5206.logMAR, initial (left)",29167,-0.0398269303993935,0.0425512433254356,-0.123227367317247,0.0435735065184602,0.349328287608099
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5207.Final number of letters displayed (left),29167,0.419217007438283,0.359477646851494,-0.285359180390644,1.12379319526721,0.243592566062547
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5208.logMAR, final (left)",29123,-0.00265905100223203,0.00835198176814696,-0.0190289352678001,0.013710833263336,0.750214148611995
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5209.Number of rounds to result (left),29163,-0.0365119070323422,0.0412727785951758,-0.117406553078887,0.0443827390142023,0.376386360644833
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",28965,0.0232231528266372,0.00851912211270842,0.00652567348572871,0.0399206321675457,0.00643251785210617
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",28965,0.0120446516938163,0.00838109509663625,-0.00438229469559077,0.0284715980832234,0.150744767275689
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5256.Corneal hysteresis (right),28965,-0.0221891012978069,0.00855616803669516,-0.0389591906497294,-0.00541901194588438,0.00953185273460073
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5257.Corneal resistance factor (right),28965,-0.00860113882497123,0.00839865565621982,-0.0250625039111621,0.00786022626121963,0.305832319941363
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",28945,0.0123610039723339,0.00858574117901333,-0.00446704873853219,0.0291890566832001,0.15001014532581
TFAP2A,Transcription factor AP-2-alpha,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",28945,0.00630294576345653,0.00842162256979506,-0.0102034344733418,0.0228093260002548,0.454238970603333
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5264.Corneal hysteresis (left),28945,-0.00673781470447535,0.00855611201804811,-0.0235077942598496,0.0100321648508989,0.431034378659211
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X5265.Corneal resistance factor (left),28945,-0.00255772528972824,0.00842583214603287,-0.0190723562959527,0.0139569057164962,0.761477386010754
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,28996,0.160644566114355,0.149974499376742,-0.133305452664059,0.454594584892768,0.284154185908614
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47546,-0.031053960982138,0.0240250254000808,-0.0781430107662965,0.0160350888020204,0.196173381887812
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47546,-0.0353677206588926,0.0264481956162069,-0.0872061840666581,0.016470742748873,0.181155478066883
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47546,0.102379862777001,0.0652322543608636,-0.0254753557702919,0.230235081324293,0.116552548569386
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47546,-0.00948597662793705,0.0110712059419433,-0.0311855402741459,0.0122135870182718,0.391555737517291
TFAP2A,Transcription factor AP-2-alpha,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47546,0.00576668840892457,0.00993848979301504,-0.0137127515853849,0.025246128403234,0.561759720830928
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35673,0.00860698701750907,0.0108697977924028,-0.0126978166556004,0.0299117906906185,0.428478119088538
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35673,0.0314910232763094,0.0380968187313306,-0.0431787414370986,0.106160787989717,0.408477641597148
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35673,-0.0045287758598116,0.0185408712634636,-0.0408688835362002,0.031811331816577,0.807034427654966
TFAP2A,Transcription factor AP-2-alpha,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35673,-0.00746767759992868,0.0117630616430832,-0.0305232784203718,0.0155879232205145,0.525544205247028
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47607,0.0349131854833135,0.0222650965456742,-0.00872640374620787,0.0785527747128348,0.116878586816499
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47607,0.0349131854833135,0.0222650965456742,-0.00872640374620787,0.0785527747128348,0.116878586816499
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47607,-0.012720139857587,0.0164415379757265,-0.0449455542900111,0.019505274574837,0.439140316090273
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47607,-0.0280091826259083,0.0256856796499251,-0.0783531147397614,0.0223347494879449,0.275522033272465
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47607,0.058679731078059,0.0620988263318625,-0.0630339685323916,0.18039343068851,0.344698579204109
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47607,0.076114440621353,0.0449775035809798,-0.0120414663973674,0.164270347640073,0.0906060956979242
TFAP2A,Transcription factor AP-2-alpha,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47607,-0.0754086448676221,0.0676378730644714,-0.207978876073986,0.0571615863387419,0.264909754036616
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47545,0.0115714955628953,0.0127090296686921,-0.0133382025877413,0.0364811937135319,0.36257129765758
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47545,0.0131365860255489,0.0217914383675456,-0.0295746331748405,0.0558478052259383,0.546625933631505
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47545,0.015906615206549,0.010667215168391,-0.00500112652349737,0.0368143569365953,0.135930579986048
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47545,-0.00907585006879493,0.0199624443590802,-0.048202241012592,0.0300505408750022,0.649367936810371
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47545,-0.0156108788046865,0.0174362209203627,-0.0497858718085973,0.0185641141992243,0.37062878277984
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47545,0.00351472973113264,0.0140658930292519,-0.0240544206062012,0.0310838800684664,0.802685375451423
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29143,-0.0273342261595657,0.0383167216538093,-0.102435000601032,0.0477665482819005,0.475644686728857
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29143,-0.0404597658049034,0.0338008980094858,-0.106709525903496,0.0257899942936886,0.231359216018867
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29143,0.0170455067363631,0.0414222132332533,-0.0641420312008133,0.0982330446735395,0.680717926565607
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29143,-0.0350557032481079,0.034231362876829,-0.102149174486693,0.0320377679904769,0.305843700742082
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47501,0.073488925388684,0.0351174655102561,0.004658692988582,0.142319157788786,0.036390125193814
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47501,0.0270389337349428,0.0509755805651402,-0.0728732041727321,0.126951071642618,0.595819403667799
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47501,0.117675567698542,0.107077934901614,-0.0921971847086208,0.327548320105704,0.271791815210886
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47501,0.147231490841956,0.0865360670079048,-0.0223792004935373,0.316842182177449,0.0888831620754443
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47501,-0.0323035267403804,0.0325017648831593,-0.0960069859113727,0.0313999324306119,0.320281387964037
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47501,-0.0133095592130834,0.0416572587952827,-0.0949577864518375,0.0683386680256707,0.74934903098239
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47501,0.00802782236537482,0.0169788364055692,-0.0252506969895409,0.0413063417202905,0.636350636187339
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32048,0.0465715791661568,0.031902180443803,-0.0159566945036971,0.109099852836011,0.144376724522634
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32048,-0.0280940398813711,0.03545198264181,-0.0975799258593188,0.0413918460965765,0.428119382772944
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32048,0.00132037645697985,0.0458632672973099,-0.0885716274457475,0.0912123803597072,0.97703324772275
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32048,-0.0151261422826593,0.0138470417418639,-0.0422663440967125,0.0120140595313938,0.274701078868725
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",33900,0.00684111646568026,0.0151652766907199,-0.0228828258481308,0.0365650587794913,0.651924361720585
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",33900,-0.0246791778331605,0.0123002490469455,-0.0487876659651736,-0.000570689701147386,0.0448407193805541
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",33900,-0.0112600314249521,0.0121686481352512,-0.0351105817700443,0.0125905189201402,0.354815824160885
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",33901,0.0264230057763785,0.0292592810993459,-0.0309251851783395,0.0837711967310964,0.366513549687681
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",33901,0.0246878723524808,0.0191056901276797,-0.0127592802977715,0.0621350250027331,0.196326697747168
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",33901,-0.0349059185943411,0.0242566564524125,-0.0824489652410696,0.0126371280523875,0.150174802508211
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47545,0.0134237120229731,0.0298296069880661,-0.0450423176736365,0.0718897417195826,0.652705159013177
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47545,0.0282290204423187,0.0191702214862302,-0.00934461367069241,0.0658026545553299,0.140886958729959
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47545,0.00445315404723822,0.0583432861243336,-0.109899686756456,0.118805994850932,0.939159780532362
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47545,0.0179036574438782,0.0217256694838229,-0.0246786547444146,0.060485969632171,0.409903245307791
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47545,-0.00987175560234136,0.0240686878599863,-0.0570463838079144,0.0373028726032317,0.681700135825811
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47545,0.0508276641821356,0.0261189249588291,-0.00036542873716941,0.102020757101441,0.0516654643915796
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47545,-0.00406051592030114,0.00854279962260026,-0.0208044031805977,0.0126833713399954,0.634567259661561
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27443,0.0348672138425535,0.0270367445022781,-0.0181248053819116,0.0878592330670186,0.19726474149017
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27443,0.0292920564749252,0.0344832121044598,-0.0382950392498161,0.0968791521996665,0.395682984506587
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27443,0.000504308521099961,0.0253605687580892,-0.0492024062447548,0.0502110232869547,0.984135790134856
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27443,-0.0148934242693545,0.0213620770083656,-0.0567630952057511,0.0269762466670421,0.485729193398437
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47654,0.00679406822238954,0.00917008175475947,-0.011179292016939,0.0247674284617181,0.458764385638853
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47654,0.010927600963766,0.0266186797454625,-0.0412450113373404,0.0631002132648724,0.681425461292809
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47654,-0.00934950425961954,0.00923158177615101,-0.0274434045408755,0.00874439602163645,0.311178510823811
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47654,-0.0200199663427632,0.00897851056809015,-0.0376178470562199,-0.00242208562930648,0.0257723584102613
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47654,-0.00263752071369677,0.0130568507464297,-0.028228948176699,0.0229539067493054,0.83991624397314
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47654,0.0163216321205991,0.0132995509233545,-0.00974548768917571,0.0423887519303738,0.219747613862077
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47654,0.00342332969697521,0.00990495026021364,-0.0159903728130435,0.0228370322069939,0.729632826732862
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47654,-0.0210581944610166,0.0277316962965838,-0.0754123192023208,0.0332959302802876,0.447647915168411
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,39943,7.65830433387358e-05,0.00974916394559484,-0.0190317782900272,0.0191849443767046,0.993732503630884
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,39943,-0.00637169432377652,0.0102297222062165,-0.0264219498479608,0.0136785612004078,0.533384743549454
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,39943,0.00196778094011112,0.0122155416984152,-0.0219746807887827,0.0259102426690049,0.872025872384017
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,39944,0.00156258487567903,0.0167663866647865,-0.0312995329873025,0.0344247027386605,0.925747842364737
TFAP2A,Transcription factor AP-2-alpha,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,39944,0.00786400785285963,0.0108326182404159,-0.0133679238983556,0.0290959396040749,0.467876101492144
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47454,0.00534008986524045,0.010134363669515,-0.0145232629270089,0.0252034426574898,0.598247865294618
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47454,0.0037452175099606,0.00796291684858543,-0.0118620995132669,0.019352534533188,0.638121925525359
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47454,0.0146860723588929,0.00948801617231624,-0.0039104393388469,0.0332825840566328,0.121670646455618
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47454,0.00393910558587246,0.014802712373298,-0.0250742106657916,0.0329524218375365,0.790159118709751
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47469,-0.0037267352653949,0.00872348067994475,-0.0208247573980866,0.0133712868672968,0.669232187452626
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47469,-0.00440088888219335,0.0121029970247678,-0.0281227630507382,0.0193209852863515,0.716145224446575
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47545,0.0127535447171215,0.00922151532836006,-0.00532062532646423,0.0308277147607072,0.166671618221722
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47545,0.00104112088846258,0.011414256151761,-0.021330821168989,0.0234130629459142,0.927324649939396
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47545,0.00026035664254506,0.0169268385048331,-0.0329162468269278,0.0334369601120179,0.987728118184861
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47545,0.00884586460742869,0.0201835033213936,-0.0307138019025028,0.0484055311173602,0.661193109236153
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47545,0.0188562224398518,0.0194885808722587,-0.0193413960697751,0.0570538409494788,0.333277858362982
TFAP2A,Transcription factor AP-2-alpha,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47545,-0.0100314434030332,0.0283692586203673,-0.0656351902989532,0.0455723034928867,0.723639878273208
TFAP2A,Transcription factor AP-2-alpha,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37263,-0.000862747618397303,0.0056147283473296,-0.0118676151791633,0.0101421199423687,0.877881759401461
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X864.Number of days or week walked 10+ minutes,47207,-0.0368297202249753,0.0196171210814624,-0.0752792775446416,0.00161983709469094,0.0604720023320618
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X874.Duration of walks,44120,-0.0102810086729231,0.0041549417079973,-0.0184246944205978,-0.00213732292524844,0.0133539557987235
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46578,-0.0232253279519264,0.01938530170913,-0.0612205193018211,0.0147698633979684,0.230894647741344
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X894.Duration of moderate activity,41441,0.0130286589846667,0.0230708082921995,-0.0321901252680443,0.0582474432373776,0.572268127685727
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X90087.No-wear time bias adjusted average acceleration,29075,-0.00302972659236557,0.00890295855940849,-0.0204795253688062,0.0144200721840751,0.73364011208145
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46590,0.00945342163393616,0.0196188487066669,-0.028999521831131,0.0479063650990033,0.629914273174956
TFAP2A,Transcription factor AP-2-alpha,Physical activities,X914.Duration of vigorous activity,37235,-0.00068318416866003,0.0053733936191816,-0.011215035662256,0.00984866732493591,0.898829898126736
